Ericlam personal page - To The Moon

Ericlam

Ericlam

Eric

739Follow

268Followers

0Topic

0Badge

2022-06-12

Happy 8th Anniversary.I love Tiger as user friendly.Able me to trade in Singapore,Australia,Hongkong,China and US stock market.I am proud owning Tiger stocks too.Prosper together with Tiger.Love the Tiger coin as it becomes my daily routine to read news and accumulate the coins to offset some fees.Good trading platform.Cheers

2022-02-10

Ready to take off

Alibaba Shares Jumped over 3% in Morning Trading

2021-05-01

Go for Xpeng

Sorry, the original content has been removed

2021-09-12

Yes,definitely is a good investment in these companies

Sorry, the original content has been removed

2021-09-02

Good sign

Sorry, the original content has been removed

2021-08-10

Unbelievable

Sorry, the original content has been removed

2021-04-30

Only can stare at the share price

Amazon sales surge 44% as it smashes earnings expectations

2021-09-21

Getting ready and trade safely

Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%

2021-08-21

Stay invested

Wall Street rallies as Fed jitters ease, but posts weekly loss

2021-06-09

Not in bitcoin

Sorry, the original content has been removed

09-08

$Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$

2022-04-03

Great to own them

7 Blue-Chip Stocks to Buy for April 2022

2022-02-28

This is a good bet🤣

Sorry, the original content has been removed

2021-12-30

Good

Sorry, the original content has been removed

2021-09-24

Nice

EngageSmart opens for trading at $37, up about 43.6% from IPO price

2021-09-17

Trade safely

S&P ends modestly lower as rising Treasury yields offset robust retail data

2021-06-23

Yes,more positive news that will boost the market

U.S. Fed bank stress tests pave way for stock buyback, dividend bonanza

2021-06-16

Great sharing shall watch the impact

Quad-Witch Quandary: How Will Friday's $2 Trillion Gamma Expiration Impact Markets

2021-06-12

Good news more vaccines

Novavax says COVID-19 vaccine shows immune response against Beta virus variant

06:40

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3559787818034959","uuid":"3559787818034959","gmtCreate":1596695020477,"gmtModify":1634349872248,"name":"Ericlam","pinyin":"ericlam","introduction":"","introductionEn":"","signature":"Eric","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","hatId":"ca_profile_frame_DWr5S1","hatName":"","vip":1,"status":2,"fanSize":268,"headSize":739,"tweetSize":1028,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.24","exceedPercentage":"80.30%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"60.22%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":35,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":510604230484112,"gmtCreate":1765672845715,"gmtModify":1765672849214,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/TSM\">$Taiwan Semiconductor Manufacturing(TSM)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TSM\">$Taiwan Semiconductor Manufacturing(TSM)$&nbsp;</a>&nbsp;","text":"$Taiwan Semiconductor Manufacturing(TSM)$","images":[{"img":"https://community-static.tradeup.com/news/a383aa1ce4f76905a83038a9103152bc","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/510604230484112","isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":510574240498296,"gmtCreate":1765665613696,"gmtModify":1765665617428,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/QLYS\">$Qualys(QLYS)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/QLYS\">$Qualys(QLYS)$</a>&nbsp;","text":"$Qualys(QLYS)$","images":[{"img":"https://community-static.tradeup.com/news/a05d5ff76d8818f25326c816c20ac48f","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/510574240498296","isVote":1,"tweetType":1,"viewCount":7,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":485087308755792,"gmtCreate":1759459855439,"gmtModify":1759461504605,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Hi My favourite <a href=\"https://ttm.financial/U/3559581955535845\"> @koolgal </a>","listText":"Hi My favourite <a href=\"https://ttm.financial/U/3559581955535845\"> @koolgal </a>","text":"Hi My favourite @koolgal","images":[{"img":"https://community-static.tradeup.com/news/720e2d95a75429d8e9ab6b284a97e717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/485087308755792","isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":480111153767136,"gmtCreate":1758238798216,"gmtModify":1758238801822,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/09988\">$BABA-W(09988)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/09988\">$BABA-W(09988)$&nbsp;</a>&nbsp;","text":"$BABA-W(09988)$","images":[{"img":"https://community-static.tradeup.com/news/51e331263837b3741fd7e02c5bad443f","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/480111153767136","isVote":1,"tweetType":1,"viewCount":794,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":476208223433544,"gmtCreate":1757289096158,"gmtModify":1757296499895,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/600276\">$Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/600276\">$Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$</a>&nbsp;","text":"$Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$","images":[{"img":"https://community-static.tradeup.com/news/0ad5f6a1cee5b95385d092aae759fdee","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/476208223433544","isVote":1,"tweetType":1,"viewCount":988,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":475131775918840,"gmtCreate":1757022475995,"gmtModify":1757022638041,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/FID.AU\">$FIDUCIAN GROUP LTD(FID.AU)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/FID.AU\">$FIDUCIAN GROUP LTD(FID.AU)$</a>&nbsp;","text":"$FIDUCIAN GROUP LTD(FID.AU)$","images":[{"img":"https://community-static.tradeup.com/news/248e45a8621df1c4a88657891638a9e6","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/475131775918840","isVote":1,"tweetType":1,"viewCount":1019,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":471234502746464,"gmtCreate":1756084841629,"gmtModify":1756084844798,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/00867\">$CMS(00867)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/00867\">$CMS(00867)$</a>&nbsp;","text":"$CMS(00867)$","images":[{"img":"https://community-static.tradeup.com/news/44c5ad08ffdae6eda34c96f9aa6e8de0","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/471234502746464","isVote":1,"tweetType":1,"viewCount":1266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":469452052877360,"gmtCreate":1755650397737,"gmtModify":1755650400212,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/469452052877360","repostId":"2560161971","repostType":4,"repost":{"id":"2560161971","kind":"live","pubTimestamp":1755614108,"share":"https://ttm.financial/m/news/2560161971?lang=&edition=fundamental","pubTime":"2025-08-19 22:35","market":"us","language":"en","title":"Xpeng Jumps 5% After Reporting Record Quarterly Revenue, Net Loss Narrows to 5-Year Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2560161971","media":"CnEVPost","summary":"Xpeng reported record quarterly revenue and further reduced its net loss to a five-year low, driven ","content":"<div>\n<p>Xpeng reported record quarterly revenue and further reduced its net loss to a five-year low, driven by strong growth in vehicle deliveries.XPeng’s U.S.-listed shares jumped 5% while its rival NIO ...</p>\n\n<a href=\"https://cnevpost.com/2025/08/19/xpeng-q2-2025-earnings/\">Web Link</a>\n\n</div>\n","source":"cnevpost_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xpeng Jumps 5% After Reporting Record Quarterly Revenue, Net Loss Narrows to 5-Year Low</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXpeng Jumps 5% After Reporting Record Quarterly Revenue, Net Loss Narrows to 5-Year Low\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-19 22:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://cnevpost.com/2025/08/19/xpeng-q2-2025-earnings/><strong>CnEVPost</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Xpeng reported record quarterly revenue and further reduced its net loss to a five-year low, driven by strong growth in vehicle deliveries.XPeng’s U.S.-listed shares jumped 5% while its rival NIO ...</p>\n\n<a href=\"https://cnevpost.com/2025/08/19/xpeng-q2-2025-earnings/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车","BK1575":"同股不同权","LU0593848301.USD":"未来资产亚洲卓越消费股票基金A","BK1539":"汽车股","BK1610":"ETF&股票定投概念","BK1119":"汽车制造商","BK1588":"回港中概股","BK1587":"次新股","09868":"小鹏汽车-W"},"source_url":"https://cnevpost.com/2025/08/19/xpeng-q2-2025-earnings/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2560161971","content_text":"Xpeng reported record quarterly revenue and further reduced its net loss to a five-year low, driven by strong growth in vehicle deliveries.XPeng’s U.S.-listed shares jumped 5% while its rival NIO gained over 6%The company reported revenue of RMB 18.27 billion ($2.55 billion) for the second quarter, up 125.3 percent year-on-year and up 15.6 percent quarter-on-quarter, according to its unaudited financial results released today.Notably, this marks Xpeng's highest quarterly revenue on record, though it still fell slightly short of Wall Street analysts' expectations of RMB 18.38 billion.In the second quarter, Xpeng delivered a record 103,181 vehicles, within the guidance range of 102,000 to 108,000 vehicles, slightly below analysts' expectations of 105,000 vehicles.Deliveries for the quarter increased by 241.58 percent year-on-year and up 9.76 percent quarter-on-quarter.Xpeng's net loss for the second quarter was RMB 480 million, a new low since the third quarter of 2020, representing a year-on-year decrease of 62.81 percent and a quarter-on-quarter decrease of 28.05 percent.Under non-GAAP, adjusted net loss for the second quarter was RMB 390 million, compared to RMB 1.22 billion in the same period of 2024 and RMB 430 million in the first quarter of 2025.Xpeng's second-quarter revenues from vehicle sales was RMB 16.88 billion, up 147.6 percent year-on-year and up 17.5 percent quarter-on-quarter, primarily driven by increased vehicle deliveries.Its second-quarter service and other revenue was RMB 1.39 billion, up 7.6 percent year-on-year but down 3.5 percent quarter-on-quarter.The year-on-year increase was primarily attributable to growth in revenue from parts and accessories sales as cumulative vehicle sales increased. The quarter-on-quarter decrease was primarily attributable to fluctuations in revenue from technology R&D services, Xpeng said.The company's gross margin for the second quarter was a record 17.3 percent, compared to 14.0 percent in the same period of 2024 and 15.6 percent in the first quarter.Xpeng reports record quarterly revenue, net loss narrows to 5-year lowThe second-quarter vehicle margin reached a record 14.3 percent, compared to 6.4 percent in the same period of 2024 and 10.5 percent in the first quarter of 2025. These increases were primarily attributed to ongoing cost reductions and optimization of the vehicle model product mix, according to Xpeng.Xpeng reports record quarterly revenue, net loss narrows to 5-year lowThe company's service and others margin for the second quarter was 53.6 percent, compared to 54.3 percent in the same period of 2024 and 66.4 percent in the first quarter. The sequential decline was primarily due to fluctuations related to technology R&D services.The company's R&D expenses for the second quarter were RMB 2.21 billion, up 50.4 percent year-on-year and up 11.4 percent quarter-on-quarter, mainly due to increased expenses related to new vehicle models and technology development.Sales, general and administrative expenses for the second quarter were RMB 2.17 billion, up 37.7 percent year-on-year and up 11.4 percent quarter-on-quarter. This was mainly due to increased franchisee commissions, marketing and advertising expenses.As of June 30, 2025, the company held cash and cash equivalents, restricted cash, short-term investments, and time deposits totaling RMB 47.57 billion, compared to RMB 41.96 billion as of December 31, 2025.Xpeng guided third-quarter vehicle deliveries to be between 113,000 and 118,000 units, representing a year-on-year increase of about 142.8 percent to 153.6 percent.This guidance implies that Xpeng expects to deliver a cumulative total of 76,283 to 81,283 vehicles in August and September, considering the 36,717 vehicles delivered in July.The company guided third-quarter revenue to be between RMB 19.6 billion and RMB 21.0 billion, representing a year-on-year increase of about 94.0 percent to 107.9 percent.","news_type":1,"symbols_score_info":{"XPEV":1.1,"09868":0.9}},"isVote":1,"tweetType":1,"viewCount":949,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":469405530288168,"gmtCreate":1755650306356,"gmtModify":1755650308601,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/469405530288168","repostId":"1116300138","repostType":2,"repost":{"id":"1116300138","kind":"news","weMediaInfo":{"introduction":"Global Stock Market Deep Analysis","home_visible":1,"media_name":"Deep News","id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"pubTimestamp":1755612253,"share":"https://ttm.financial/m/news/1116300138?lang=&edition=fundamental","pubTime":"2025-08-19 22:04","market":"hk","language":"en","title":"Financial Report Reveals \"Healthy\" Signals: Analyzing the Logic Behind JD Health's High-Quality Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1116300138","media":"Deep News","summary":"As a leading player in China's digital health market, JD Health has maintained clear development priorities in recent years: continuously strengthening supply chain capabilities as the foundation of...","content":"<p>As a leading player in China's digital health market, JD Health has maintained clear development priorities in recent years: continuously strengthening supply chain capabilities as the foundation of business operations, while focusing on enhancing medical service capabilities, particularly building integrated online and offline service systems and complete service loops.</p>\n<p>In JD Health's underlying business logic, empowering partners represents a crucial component, making collaborative growth with partners one of JD Health's long-term strategies. Business-related dynamic events serve as important windows for investors to observe how JD Health advances its long-term strategy.</p>\n<p>On August 15, the day after announcing its interim results, JD Health reached a strategic cooperation agreement with Eisai China. Through this partnership, Lemborexant (brand name: Dayvigo), an insomnia treatment drug developed by Eisai China, will launch exclusively online through JD Health following regulatory approval. Lemborexant represents China's first non-sedating anti-insomnia new drug, potentially reshaping the anti-insomnia pharmaceutical market.</p>\n<p>This development aligns with strengthening supply chain advantages and corresponds to JD Health's core long-term development direction. The interim financial report released on August 14 showed that over 30 innovative drugs launched online through JD Health in the first half of this year, alongside collaborations with multiple medical device and nutritional health brands, achieving online debuts for numerous products across the entire network.</p>\n<p>These developments confirm JD Health's efforts to further consolidate its core competitive advantages: supply chain capabilities and brand empowerment value. The synergy between these elements has facilitated extensive collaborations, creating advantages in debut product quantities beyond the existing advantages in pharmaceutical and health product category numbers.</p>\n<p>**Service Model Innovation Becomes Second Growth Curve**</p>\n<p>In recent years, a core trend in the digital medical industry has been online-offline integration. Major players are refining traditional online channel capabilities while prioritizing the fusion of online and offline services and complete connectivity across the entire chain.</p>\n<p>For internet medical companies like JD Health, the main business includes pharmaceutical retail and medical services. The business core integrates these two major segments, creating a complete \"medical testing, diagnosis, and medication\" service loop. Internet hospitals serve as key components in this service loop, with their service capabilities in various disease specialties directly determining service depth and breadth.</p>\n<p>Through long-term development, JD Health has effectively explored internet medical specialty service models in five major areas: dermatology, mental health, traditional Chinese medicine, oncology, and men's health.</p>\n<p>As a new-type medical health service enterprise, JD Health focuses on deepening and specializing online services while emphasizing \"home delivery\" capabilities for offline services. Examples include nurse home visits and home rapid testing services, with service levels primarily reflected in \"breadth\" and \"speed.\"</p>\n<p>\"Breadth\" refers to nurse home visit services expanding to 7 categories and 64 items, while home rapid testing currently provides over 160 rapid testing services. \"Speed\" means nurse home visits can achieve order acceptance in as fast as 3 minutes and door-to-door service within 1 hour.</p>\n<p>These service capabilities demonstrate their value in specific demand scenarios. Taking flu as an example, during flu season, users can quickly determine flu types through JD Health's home rapid testing service, with subsequent consultations, medication purchases, and follow-ups completed online, typically finishing the entire process within one day.</p>\n<p>**Weight Management Business Layout Demonstrates Strategic Extension**</p>\n<p>JD Health's weight management business layout represents both an extension of existing business strategy and a typical case of multi-win outcomes. This year, weight management has become a nationally discussed topic, driven by continuously growing obesity populations and sustained strong demand, alongside GLP-1 drugs like semaglutide expanding into weight loss indications, reshaping the weight loss drug market and accelerating market growth.</p>\n<p>Based on current market expectations, GLP-1 drugs with weight loss indications could reach trillion-scale market potential. JD Health's related business layout includes strategic cooperation with Novo Nordisk, the original developer of semaglutide. Mazdutide (brand name: Xinermei) from Innovent Biologics launched exclusively on JD Health immediately after approval, with search volume for \"Xinermei\" exceeding one million on the JD platform between July 4 and August 4, serving over 30,000 users.</p>\n<p>**User Growth and Stickiness Drive Performance Improvement**</p>\n<p>JD Health's 2025 interim financial report shows revenue of 35.3 billion yuan in the first half of 2025, representing 24.5% year-over-year growth, not only exceeding market expectations but achieving the strongest half-year growth rate since the end of the pandemic in 2023. Operationally, active users exceeded 200 million by the first half of 2025, achieving a milestone breakthrough.</p>\n<p>The core highlights of JD Health's financial report are revenue growth and attribution for pharmaceutical e-commerce and medical services, the two main businesses. Pharmaceutical e-commerce has maintained revenue proportions above 83% in recent years, serving as the company's performance foundation, achieving 29.3 billion yuan revenue in the first half of 2025, up 23% year-over-year.</p>\n<p>Medical services have shown stronger growth momentum than pharmaceutical e-commerce in recent years, serving as an important marginal force driving company performance growth, with first-half revenue of 6 billion yuan, up 34% year-over-year.</p>\n<p>Pharmaceutical e-commerce revenue growth primarily benefits from active user growth and increased per-user purchase amounts, essentially reflecting how supply chain and service capabilities support continuous product category enrichment and complete service loop experience optimization, creating positive resonance with JD Health's brand value and improving user mindshare and online sales penetration during the reporting period.</p>\n<p>**AI Upgrade Provides Important Valuation Support**</p>\n<p>Following the financial report release, investors responded positively to JD Health's performance, with the company's stock price surging 21% cumulatively over two trading days on August 15 and 18. Particularly on August 15, the day after the financial report release, intraday gains exceeded 16% at their peak, ultimately closing up 12%.</p>\n<p>JD Health's post-earnings stock surge stems partly from market recognition of its performance and underlying business model. Leveraging supply chain advantages, JD Health has built an integrated \"supply chain + service + technology\" ecosystem and complete \"medical testing, diagnosis, and medication\" service loop, creating significant differentiation from peers and demonstrating considerable scarcity value in capital markets due to its difficult-to-replicate characteristics.</p>\n<p>Another factor is investor response to JD Health's strong AI concept attributes. According to this quarter's financial report, JD Health launched the \"AI Jingyi\" product series in the first half of this year, covering multi-role professional service intelligent agents for users, including AI doctors, AI pharmacists, and AI psychological counselors, along with digital avatars and AI assistants for doctors. During the reporting period, \"AI Jingyi\" served over 50 million users cumulatively.</p>\n<p>For hospital AI upgrades, JD Health introduced its first hospital full-scenario product \"JD Zhuoyi,\" primarily providing AI upgrades for three main \"entities\": individual users, doctors, and hospital operations management. This has been implemented in multiple medical institutions, such as the AI-driven outpatient patient service process loop created through JD Health's collaboration with the First Affiliated Hospital of Wenzhou Medical University, which has served over 2.2 million patient visits.</p>\n<p>Currently, AI field attention has shifted toward applications, and JD Health, as an important industry participant, has continuously focused on application-level development in AI upgrades in recent years, aligning with industry trends while achieving significant results.</p>\n<p>Long-term, JD Health's continued investment and innovation in AI may break through traditional internet medical enterprise growth bottlenecks, with AI's role as a third growth curve becoming increasingly prominent, helping the company improve valuation levels in capital markets.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Financial Report Reveals \"Healthy\" Signals: Analyzing the Logic Behind JD Health's High-Quality Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFinancial Report Reveals \"Healthy\" Signals: Analyzing the Logic Behind JD Health's High-Quality Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-08-19 22:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>As a leading player in China's digital health market, JD Health has maintained clear development priorities in recent years: continuously strengthening supply chain capabilities as the foundation of business operations, while focusing on enhancing medical service capabilities, particularly building integrated online and offline service systems and complete service loops.</p>\n<p>In JD Health's underlying business logic, empowering partners represents a crucial component, making collaborative growth with partners one of JD Health's long-term strategies. Business-related dynamic events serve as important windows for investors to observe how JD Health advances its long-term strategy.</p>\n<p>On August 15, the day after announcing its interim results, JD Health reached a strategic cooperation agreement with Eisai China. Through this partnership, Lemborexant (brand name: Dayvigo), an insomnia treatment drug developed by Eisai China, will launch exclusively online through JD Health following regulatory approval. Lemborexant represents China's first non-sedating anti-insomnia new drug, potentially reshaping the anti-insomnia pharmaceutical market.</p>\n<p>This development aligns with strengthening supply chain advantages and corresponds to JD Health's core long-term development direction. The interim financial report released on August 14 showed that over 30 innovative drugs launched online through JD Health in the first half of this year, alongside collaborations with multiple medical device and nutritional health brands, achieving online debuts for numerous products across the entire network.</p>\n<p>These developments confirm JD Health's efforts to further consolidate its core competitive advantages: supply chain capabilities and brand empowerment value. The synergy between these elements has facilitated extensive collaborations, creating advantages in debut product quantities beyond the existing advantages in pharmaceutical and health product category numbers.</p>\n<p>**Service Model Innovation Becomes Second Growth Curve**</p>\n<p>In recent years, a core trend in the digital medical industry has been online-offline integration. Major players are refining traditional online channel capabilities while prioritizing the fusion of online and offline services and complete connectivity across the entire chain.</p>\n<p>For internet medical companies like JD Health, the main business includes pharmaceutical retail and medical services. The business core integrates these two major segments, creating a complete \"medical testing, diagnosis, and medication\" service loop. Internet hospitals serve as key components in this service loop, with their service capabilities in various disease specialties directly determining service depth and breadth.</p>\n<p>Through long-term development, JD Health has effectively explored internet medical specialty service models in five major areas: dermatology, mental health, traditional Chinese medicine, oncology, and men's health.</p>\n<p>As a new-type medical health service enterprise, JD Health focuses on deepening and specializing online services while emphasizing \"home delivery\" capabilities for offline services. Examples include nurse home visits and home rapid testing services, with service levels primarily reflected in \"breadth\" and \"speed.\"</p>\n<p>\"Breadth\" refers to nurse home visit services expanding to 7 categories and 64 items, while home rapid testing currently provides over 160 rapid testing services. \"Speed\" means nurse home visits can achieve order acceptance in as fast as 3 minutes and door-to-door service within 1 hour.</p>\n<p>These service capabilities demonstrate their value in specific demand scenarios. Taking flu as an example, during flu season, users can quickly determine flu types through JD Health's home rapid testing service, with subsequent consultations, medication purchases, and follow-ups completed online, typically finishing the entire process within one day.</p>\n<p>**Weight Management Business Layout Demonstrates Strategic Extension**</p>\n<p>JD Health's weight management business layout represents both an extension of existing business strategy and a typical case of multi-win outcomes. This year, weight management has become a nationally discussed topic, driven by continuously growing obesity populations and sustained strong demand, alongside GLP-1 drugs like semaglutide expanding into weight loss indications, reshaping the weight loss drug market and accelerating market growth.</p>\n<p>Based on current market expectations, GLP-1 drugs with weight loss indications could reach trillion-scale market potential. JD Health's related business layout includes strategic cooperation with Novo Nordisk, the original developer of semaglutide. Mazdutide (brand name: Xinermei) from Innovent Biologics launched exclusively on JD Health immediately after approval, with search volume for \"Xinermei\" exceeding one million on the JD platform between July 4 and August 4, serving over 30,000 users.</p>\n<p>**User Growth and Stickiness Drive Performance Improvement**</p>\n<p>JD Health's 2025 interim financial report shows revenue of 35.3 billion yuan in the first half of 2025, representing 24.5% year-over-year growth, not only exceeding market expectations but achieving the strongest half-year growth rate since the end of the pandemic in 2023. Operationally, active users exceeded 200 million by the first half of 2025, achieving a milestone breakthrough.</p>\n<p>The core highlights of JD Health's financial report are revenue growth and attribution for pharmaceutical e-commerce and medical services, the two main businesses. Pharmaceutical e-commerce has maintained revenue proportions above 83% in recent years, serving as the company's performance foundation, achieving 29.3 billion yuan revenue in the first half of 2025, up 23% year-over-year.</p>\n<p>Medical services have shown stronger growth momentum than pharmaceutical e-commerce in recent years, serving as an important marginal force driving company performance growth, with first-half revenue of 6 billion yuan, up 34% year-over-year.</p>\n<p>Pharmaceutical e-commerce revenue growth primarily benefits from active user growth and increased per-user purchase amounts, essentially reflecting how supply chain and service capabilities support continuous product category enrichment and complete service loop experience optimization, creating positive resonance with JD Health's brand value and improving user mindshare and online sales penetration during the reporting period.</p>\n<p>**AI Upgrade Provides Important Valuation Support**</p>\n<p>Following the financial report release, investors responded positively to JD Health's performance, with the company's stock price surging 21% cumulatively over two trading days on August 15 and 18. Particularly on August 15, the day after the financial report release, intraday gains exceeded 16% at their peak, ultimately closing up 12%.</p>\n<p>JD Health's post-earnings stock surge stems partly from market recognition of its performance and underlying business model. Leveraging supply chain advantages, JD Health has built an integrated \"supply chain + service + technology\" ecosystem and complete \"medical testing, diagnosis, and medication\" service loop, creating significant differentiation from peers and demonstrating considerable scarcity value in capital markets due to its difficult-to-replicate characteristics.</p>\n<p>Another factor is investor response to JD Health's strong AI concept attributes. According to this quarter's financial report, JD Health launched the \"AI Jingyi\" product series in the first half of this year, covering multi-role professional service intelligent agents for users, including AI doctors, AI pharmacists, and AI psychological counselors, along with digital avatars and AI assistants for doctors. During the reporting period, \"AI Jingyi\" served over 50 million users cumulatively.</p>\n<p>For hospital AI upgrades, JD Health introduced its first hospital full-scenario product \"JD Zhuoyi,\" primarily providing AI upgrades for three main \"entities\": individual users, doctors, and hospital operations management. This has been implemented in multiple medical institutions, such as the AI-driven outpatient patient service process loop created through JD Health's collaboration with the First Affiliated Hospital of Wenzhou Medical University, which has served over 2.2 million patient visits.</p>\n<p>Currently, AI field attention has shifted toward applications, and JD Health, as an important industry participant, has continuously focused on application-level development in AI upgrades in recent years, aligning with industry trends while achieving significant results.</p>\n<p>Long-term, JD Health's continued investment and innovation in AI may break through traditional internet medical enterprise growth bottlenecks, with AI's role as a third growth curve becoming increasingly prominent, helping the company improve valuation levels in capital markets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"86618":"京东健康-R","BK1583":"高瓴概念","LU0051755006.USD":"摩根大通中国A (dist)","BK1571":"互联网医疗","BK1589":"北水核心资产","06618":"京东健康","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","BK1515":"抗疫概念","BK1591":"就地过年概念","BK1142":"互联网与直销零售","BK1615":"港股-互联网","BK1247":"药品零售"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116300138","content_text":"As a leading player in China's digital health market, JD Health has maintained clear development priorities in recent years: continuously strengthening supply chain capabilities as the foundation of business operations, while focusing on enhancing medical service capabilities, particularly building integrated online and offline service systems and complete service loops.\nIn JD Health's underlying business logic, empowering partners represents a crucial component, making collaborative growth with partners one of JD Health's long-term strategies. Business-related dynamic events serve as important windows for investors to observe how JD Health advances its long-term strategy.\nOn August 15, the day after announcing its interim results, JD Health reached a strategic cooperation agreement with Eisai China. Through this partnership, Lemborexant (brand name: Dayvigo), an insomnia treatment drug developed by Eisai China, will launch exclusively online through JD Health following regulatory approval. Lemborexant represents China's first non-sedating anti-insomnia new drug, potentially reshaping the anti-insomnia pharmaceutical market.\nThis development aligns with strengthening supply chain advantages and corresponds to JD Health's core long-term development direction. The interim financial report released on August 14 showed that over 30 innovative drugs launched online through JD Health in the first half of this year, alongside collaborations with multiple medical device and nutritional health brands, achieving online debuts for numerous products across the entire network.\nThese developments confirm JD Health's efforts to further consolidate its core competitive advantages: supply chain capabilities and brand empowerment value. The synergy between these elements has facilitated extensive collaborations, creating advantages in debut product quantities beyond the existing advantages in pharmaceutical and health product category numbers.\n**Service Model Innovation Becomes Second Growth Curve**\nIn recent years, a core trend in the digital medical industry has been online-offline integration. Major players are refining traditional online channel capabilities while prioritizing the fusion of online and offline services and complete connectivity across the entire chain.\nFor internet medical companies like JD Health, the main business includes pharmaceutical retail and medical services. The business core integrates these two major segments, creating a complete \"medical testing, diagnosis, and medication\" service loop. Internet hospitals serve as key components in this service loop, with their service capabilities in various disease specialties directly determining service depth and breadth.\nThrough long-term development, JD Health has effectively explored internet medical specialty service models in five major areas: dermatology, mental health, traditional Chinese medicine, oncology, and men's health.\nAs a new-type medical health service enterprise, JD Health focuses on deepening and specializing online services while emphasizing \"home delivery\" capabilities for offline services. Examples include nurse home visits and home rapid testing services, with service levels primarily reflected in \"breadth\" and \"speed.\"\n\"Breadth\" refers to nurse home visit services expanding to 7 categories and 64 items, while home rapid testing currently provides over 160 rapid testing services. \"Speed\" means nurse home visits can achieve order acceptance in as fast as 3 minutes and door-to-door service within 1 hour.\nThese service capabilities demonstrate their value in specific demand scenarios. Taking flu as an example, during flu season, users can quickly determine flu types through JD Health's home rapid testing service, with subsequent consultations, medication purchases, and follow-ups completed online, typically finishing the entire process within one day.\n**Weight Management Business Layout Demonstrates Strategic Extension**\nJD Health's weight management business layout represents both an extension of existing business strategy and a typical case of multi-win outcomes. This year, weight management has become a nationally discussed topic, driven by continuously growing obesity populations and sustained strong demand, alongside GLP-1 drugs like semaglutide expanding into weight loss indications, reshaping the weight loss drug market and accelerating market growth.\nBased on current market expectations, GLP-1 drugs with weight loss indications could reach trillion-scale market potential. JD Health's related business layout includes strategic cooperation with Novo Nordisk, the original developer of semaglutide. Mazdutide (brand name: Xinermei) from Innovent Biologics launched exclusively on JD Health immediately after approval, with search volume for \"Xinermei\" exceeding one million on the JD platform between July 4 and August 4, serving over 30,000 users.\n**User Growth and Stickiness Drive Performance Improvement**\nJD Health's 2025 interim financial report shows revenue of 35.3 billion yuan in the first half of 2025, representing 24.5% year-over-year growth, not only exceeding market expectations but achieving the strongest half-year growth rate since the end of the pandemic in 2023. Operationally, active users exceeded 200 million by the first half of 2025, achieving a milestone breakthrough.\nThe core highlights of JD Health's financial report are revenue growth and attribution for pharmaceutical e-commerce and medical services, the two main businesses. Pharmaceutical e-commerce has maintained revenue proportions above 83% in recent years, serving as the company's performance foundation, achieving 29.3 billion yuan revenue in the first half of 2025, up 23% year-over-year.\nMedical services have shown stronger growth momentum than pharmaceutical e-commerce in recent years, serving as an important marginal force driving company performance growth, with first-half revenue of 6 billion yuan, up 34% year-over-year.\nPharmaceutical e-commerce revenue growth primarily benefits from active user growth and increased per-user purchase amounts, essentially reflecting how supply chain and service capabilities support continuous product category enrichment and complete service loop experience optimization, creating positive resonance with JD Health's brand value and improving user mindshare and online sales penetration during the reporting period.\n**AI Upgrade Provides Important Valuation Support**\nFollowing the financial report release, investors responded positively to JD Health's performance, with the company's stock price surging 21% cumulatively over two trading days on August 15 and 18. Particularly on August 15, the day after the financial report release, intraday gains exceeded 16% at their peak, ultimately closing up 12%.\nJD Health's post-earnings stock surge stems partly from market recognition of its performance and underlying business model. Leveraging supply chain advantages, JD Health has built an integrated \"supply chain + service + technology\" ecosystem and complete \"medical testing, diagnosis, and medication\" service loop, creating significant differentiation from peers and demonstrating considerable scarcity value in capital markets due to its difficult-to-replicate characteristics.\nAnother factor is investor response to JD Health's strong AI concept attributes. According to this quarter's financial report, JD Health launched the \"AI Jingyi\" product series in the first half of this year, covering multi-role professional service intelligent agents for users, including AI doctors, AI pharmacists, and AI psychological counselors, along with digital avatars and AI assistants for doctors. During the reporting period, \"AI Jingyi\" served over 50 million users cumulatively.\nFor hospital AI upgrades, JD Health introduced its first hospital full-scenario product \"JD Zhuoyi,\" primarily providing AI upgrades for three main \"entities\": individual users, doctors, and hospital operations management. This has been implemented in multiple medical institutions, such as the AI-driven outpatient patient service process loop created through JD Health's collaboration with the First Affiliated Hospital of Wenzhou Medical University, which has served over 2.2 million patient visits.\nCurrently, AI field attention has shifted toward applications, and JD Health, as an important industry participant, has continuously focused on application-level development in AI upgrades in recent years, aligning with industry trends while achieving significant results.\nLong-term, JD Health's continued investment and innovation in AI may break through traditional internet medical enterprise growth bottlenecks, with AI's role as a third growth curve becoming increasingly prominent, helping the company improve valuation levels in capital markets.","news_type":1,"symbols_score_info":{"86618":1,"06618":1}},"isVote":1,"tweetType":1,"viewCount":1103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":469094972682488,"gmtCreate":1755563222160,"gmtModify":1755563225370,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/VOO\">$Vanguard S&amp;P 500 ETF(VOO)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/VOO\">$Vanguard S&amp;P 500 ETF(VOO)$&nbsp;</a>&nbsp;","text":"$Vanguard S&P 500 ETF(VOO)$","images":[{"img":"https://community-static.tradeup.com/news/dfc55a21543d084bf21a1eba482048ce","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/469094972682488","isVote":1,"tweetType":1,"viewCount":1193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":467325755576760,"gmtCreate":1755130860018,"gmtModify":1755130862916,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$&nbsp;</a>&nbsp;","text":"$Apple(AAPL)$","images":[{"img":"https://community-static.tradeup.com/news/dae3476fea5fc10b72d58b8b033966d7","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/467325755576760","isVote":1,"tweetType":1,"viewCount":696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":467325531677376,"gmtCreate":1755130806244,"gmtModify":1755130810649,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$&nbsp;</a>&nbsp;","text":"$Apple(AAPL)$","images":[{"img":"https://community-static.tradeup.com/news/cc47221296177fb1ef93ffc942e187be","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/467325531677376","isVote":1,"tweetType":1,"viewCount":1235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":464961769689568,"gmtCreate":1754526268701,"gmtModify":1754526272261,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/VOO\">$Vanguard S&amp;P 500 ETF(VOO)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/VOO\">$Vanguard S&amp;P 500 ETF(VOO)$&nbsp;</a>&nbsp;","text":"$Vanguard S&P 500 ETF(VOO)$","images":[{"img":"https://community-static.tradeup.com/news/cc673951c63df4340087feb26dc0c695","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/464961769689568","isVote":1,"tweetType":1,"viewCount":773,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":464549489447504,"gmtCreate":1754440566311,"gmtModify":1754440576700,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/META\">$Meta Platforms, Inc.(META)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/META\">$Meta Platforms, Inc.(META)$&nbsp;</a>&nbsp;","text":"$Meta Platforms, Inc.(META)$","images":[{"img":"https://community-static.tradeup.com/news/60c4b4722e813c059e3f4973943ba955","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/464549489447504","isVote":1,"tweetType":1,"viewCount":705,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":456488937431144,"gmtCreate":1752450619081,"gmtModify":1752450620496,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/456488937431144","repostId":"455480773550280","repostType":1,"repost":{"id":455480773550280,"gmtCreate":1752238241442,"gmtModify":1752461996294,"author":{"id":"4176423247955812","authorId":"4176423247955812","name":"Lanceljx","avatar":"https://community-static.tradeup.com/news/09909b81957df6057776741ed24e12fe","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4176423247955812","idStr":"4176423247955812"},"themes":[],"htmlText":"📉📈 “Markets took a dive the moment tariffs hit… but when Trump hinted they were ‘off’ again? Let’s just say the S&amp;P caught a second wind.” Just one picture to sum up the first half of 2025. It's been volatile, but at least it made for a good meme. <a href=\"https://ttm.financial/U/3527667671414981\"> @TigerClub </a><a href=\"https://ttm.financial/U/3527667667103859\"> @TigerEvents </a>","listText":"📉📈 “Markets took a dive the moment tariffs hit… but when Trump hinted they were ‘off’ again? Let’s just say the S&amp;P caught a second wind.” Just one picture to sum up the first half of 2025. It's been volatile, but at least it made for a good meme. <a href=\"https://ttm.financial/U/3527667671414981\"> @TigerClub </a><a href=\"https://ttm.financial/U/3527667667103859\"> @TigerEvents </a>","text":"📉📈 “Markets took a dive the moment tariffs hit… but when Trump hinted they were ‘off’ again? Let’s just say the S&P caught a second wind.” Just one picture to sum up the first half of 2025. It's been volatile, but at least it made for a good meme. @TigerClub @TigerEvents","images":[{"img":"https://community-static.tradeup.com/news/0cb84773def01502fd6c4baf57e16eaf"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/455480773550280","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":456478153015528,"gmtCreate":1752450596824,"gmtModify":1752450598195,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/456478153015528","repostId":"455958727098440","repostType":1,"repost":{"id":455958727098440,"gmtCreate":1752326384781,"gmtModify":1752328892185,"author":{"id":"4102123614530830","authorId":"4102123614530830","name":"nerdbull1669","avatar":"https://community-static.tradeup.com/news/8ac2db9ff7976dac4aa567ce14027bd6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4102123614530830","idStr":"4102123614530830"},"themes":[],"title":"3 Stocks Analysis - What Other Indicators Improve Trading Signals Alongside Bollinger Bands and MACD?","htmlText":"If we looked how new and seasoned investors are using, I believe Bollinger Bands and MACD is not unfamiliar to us. Bollinger Bands and MACD already give us a powerful combo of volatility and momentum, but layering in complementary indicators can sharpen signal precision and reduce false positives. In this article I would like to share a curated list of high-impact additions. Indicators That Pair Well with Bollinger Bands &amp; MACD Relative Strength Index (RSI) Measures overbought/oversold conditions. Why it helps: Confirms MACD momentum shifts and Bollinger Band breakouts. Bonus: Divergence between RSI and price often precedes reversals. Volume-Weighted Average Price (VWAP) Tracks average price weighted by volume. Why it helps: Acts as dynamic support/resistance; confirms breakout legitim","listText":"If we looked how new and seasoned investors are using, I believe Bollinger Bands and MACD is not unfamiliar to us. Bollinger Bands and MACD already give us a powerful combo of volatility and momentum, but layering in complementary indicators can sharpen signal precision and reduce false positives. In this article I would like to share a curated list of high-impact additions. Indicators That Pair Well with Bollinger Bands &amp; MACD Relative Strength Index (RSI) Measures overbought/oversold conditions. Why it helps: Confirms MACD momentum shifts and Bollinger Band breakouts. Bonus: Divergence between RSI and price often precedes reversals. Volume-Weighted Average Price (VWAP) Tracks average price weighted by volume. Why it helps: Acts as dynamic support/resistance; confirms breakout legitim","text":"If we looked how new and seasoned investors are using, I believe Bollinger Bands and MACD is not unfamiliar to us. Bollinger Bands and MACD already give us a powerful combo of volatility and momentum, but layering in complementary indicators can sharpen signal precision and reduce false positives. In this article I would like to share a curated list of high-impact additions. Indicators That Pair Well with Bollinger Bands & MACD Relative Strength Index (RSI) Measures overbought/oversold conditions. Why it helps: Confirms MACD momentum shifts and Bollinger Band breakouts. Bonus: Divergence between RSI and price often precedes reversals. Volume-Weighted Average Price (VWAP) Tracks average price weighted by volume. Why it helps: Acts as dynamic support/resistance; confirms breakout legitim","images":[{"img":"https://community-static.tradeup.com/news/9f7dd912497d4e91f0eae8c5431c184d","width":"970","height":"506"},{"img":"https://community-static.tradeup.com/news/2483fb639f73c8bc42bb0033456bcb34","width":"408","height":"308"},{"img":"https://community-static.tradeup.com/news/6f754134af40781f0a594105e8422b02","width":"1614","height":"763"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/455958727098440","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":6,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":475,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":456471387414864,"gmtCreate":1752450550059,"gmtModify":1752450552212,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/456471387414864","repostId":"455524947534256","repostType":1,"repost":{"id":455524947534256,"gmtCreate":1752219973962,"gmtModify":1752351005660,"author":{"id":"4172293714339752","authorId":"4172293714339752","name":"Kiwi Tigress","avatar":"https://community-static.tradeup.com/news/44439795b309a195e7cd7613ce58f08f","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4172293714339752","idStr":"4172293714339752"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$</a> <a href=\"https://ttm.financial/S/OMAH\">$VistaShares Target 15 Berkshire Select Income ETF(OMAH)$</a>literally survived this with vibes, luck, and an unhealthy attachment to stonks 💀💸 jan was pain, june was redemption, now i’m just hoping the slay sticks💥🚀 <a href=\"https://ttm.financial/U/4186117467483482\"> @Cool Cat Winston </a><a href=\"https://ttm.financial/U/3559581955535845\"> @koolgal </a>coins up 4 grabs yo","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$</a> <a href=\"https://ttm.financial/S/OMAH\">$VistaShares Target 15 Berkshire Select Income ETF(OMAH)$</a>literally survived this with vibes, luck, and an unhealthy attachment to stonks 💀💸 jan was pain, june was redemption, now i’m just hoping the slay sticks💥🚀 <a href=\"https://ttm.financial/U/4186117467483482\"> @Cool Cat Winston </a><a href=\"https://ttm.financial/U/3559581955535845\"> @koolgal </a>coins up 4 grabs yo","text":"$NVIDIA(NVDA)$ $VistaShares Target 15 Berkshire Select Income ETF(OMAH)$literally survived this with vibes, luck, and an unhealthy attachment to stonks 💀💸 jan was pain, june was redemption, now i’m just hoping the slay sticks💥🚀 @Cool Cat Winston @koolgal coins up 4 grabs yo","images":[{"img":"https://community-static.tradeup.com/news/3f5e40cd3aa59aa6772117ff8d912f13"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/455524947534256","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":658,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":456467609612728,"gmtCreate":1752450504433,"gmtModify":1752450505855,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/456467609612728","repostId":"456072177496328","repostType":1,"repost":{"id":456072177496328,"gmtCreate":1752364875978,"gmtModify":1752364881195,"author":{"id":"3574381076586256","authorId":"3574381076586256","name":"KYHBKO","avatar":"https://static.tigerbbs.com/c3bcbc7f9a10836dea92afc94bf39b5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574381076586256","idStr":"3574381076586256"},"themes":[],"htmlText":"USA News has recently released a list of the 10 best growth stocks on 9 July 2025. How many of them are in your portfolio? Let us research before buying. <a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a> <a href=\"https://ttm.financial/S/AVGO\">$Broadcom(AVGO)$</a> <a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$</a> <a href=\"https://ttm.financial/S/NOW\">$ServiceNow(NOW)$</a>","listText":"USA News has recently released a list of the 10 best growth stocks on 9 July 2025. How many of them are in your portfolio? Let us research before buying. <a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a> <a href=\"https://ttm.financial/S/AVGO\">$Broadcom(AVGO)$</a> <a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$</a> <a href=\"https://ttm.financial/S/NOW\">$ServiceNow(NOW)$</a>","text":"USA News has recently released a list of the 10 best growth stocks on 9 July 2025. How many of them are in your portfolio? Let us research before buying. $Palantir Technologies Inc.(PLTR)$ $Broadcom(AVGO)$ $NVIDIA(NVDA)$ $ServiceNow(NOW)$","images":[{"img":"https://community-static.tradeup.com/news/d897fb480d32699c1fb2e1bb5bda30b3","width":"1752","height":"1368"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/456072177496328","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":734,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":456468136538144,"gmtCreate":1752450483758,"gmtModify":1752450487747,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/456468136538144","repostId":"455987319894720","repostType":1,"repost":{"id":455987319894720,"gmtCreate":1752362017271,"gmtModify":1752362031410,"author":{"id":"4180241841877492","authorId":"4180241841877492","name":"ARKK Investment Tracker","avatar":"https://community-static.tradeup.com/news/3f5229c0ae74f578f94958dbdf9cbd02","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4180241841877492","idStr":"4180241841877492"},"themes":[],"htmlText":"ARKK Investment Tracker position change: Increased position in SoFi Technologies Inc. by 36,448 shares, the number of shares held increased 1.77% compared to the previous period and now represents 0.61% of the total position.","listText":"ARKK Investment Tracker position change: Increased position in SoFi Technologies Inc. by 36,448 shares, the number of shares held increased 1.77% compared to the previous period and now represents 0.61% of the total position.","text":"ARKK Investment Tracker position change: Increased position in SoFi Technologies Inc. by 36,448 shares, the number of shares held increased 1.77% compared to the previous period and now represents 0.61% of the total position.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/455987319894720","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":582,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":445804310061184,"gmtCreate":1749863770253,"gmtModify":1749863771930,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/445804310061184","repostId":"445505233433016","repostType":1,"repost":{"id":445505233433016,"gmtCreate":1749791236970,"gmtModify":1749794184693,"author":{"id":"4125570196865622","authorId":"4125570196865622","name":"orsiri","avatar":"https://community-static.tradeup.com/news/65ce9f1def4b96d1cd3e7dce4d696e8e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4125570196865622","idStr":"4125570196865622"},"themes":[],"title":"Cash Over Hype: The Cool Heads Beating the Heat in China’s Wild Markets","htmlText":"Everest Medicines and BYD are quietly flexing their cash muscles—while others chase noise, these two play the long game. In a Chinese equity market where drama is currency and hype is mistaken for growth, I’ve found comfort in the steady rhythm of cash flow. Amid the chaos, <a href=\"https://ttm.financial/S/01952\">$EVEREST MED(01952)$</a> and <a href=\"https://ttm.financial/S/01211\">$BYD COMPANY(01211)$</a> are doing something wonderfully boring—and in investing, boring can be beautiful. They're quietly building value through discipline, liquidity, and hard numbers. Here’s why I believe these two companies—one a biopharma underdog, the other an EV titan—deserve a closer, calmer look. Where others chase noise, value flows in silence Everest Medicines: A Pipeline With Patience","listText":"Everest Medicines and BYD are quietly flexing their cash muscles—while others chase noise, these two play the long game. In a Chinese equity market where drama is currency and hype is mistaken for growth, I’ve found comfort in the steady rhythm of cash flow. Amid the chaos, <a href=\"https://ttm.financial/S/01952\">$EVEREST MED(01952)$</a> and <a href=\"https://ttm.financial/S/01211\">$BYD COMPANY(01211)$</a> are doing something wonderfully boring—and in investing, boring can be beautiful. They're quietly building value through discipline, liquidity, and hard numbers. Here’s why I believe these two companies—one a biopharma underdog, the other an EV titan—deserve a closer, calmer look. Where others chase noise, value flows in silence Everest Medicines: A Pipeline With Patience","text":"Everest Medicines and BYD are quietly flexing their cash muscles—while others chase noise, these two play the long game. In a Chinese equity market where drama is currency and hype is mistaken for growth, I’ve found comfort in the steady rhythm of cash flow. Amid the chaos, $EVEREST MED(01952)$ and $BYD COMPANY(01211)$ are doing something wonderfully boring—and in investing, boring can be beautiful. They're quietly building value through discipline, liquidity, and hard numbers. Here’s why I believe these two companies—one a biopharma underdog, the other an EV titan—deserve a closer, calmer look. Where others chase noise, value flows in silence Everest Medicines: A Pipeline With Patience","images":[{"img":"https://community-static.tradeup.com/news/d523dd0f5e1bfccca8b74174e953ddb2","width":"1800","height":"1800"},{"img":"https://community-static.tradeup.com/news/c4f6a0962df304d7b6a2428cb2f1b4c8","width":"2500","height":"1478"},{"img":"https://community-static.tradeup.com/news/2e01aa900199892513ca78361c97110a","width":"2500","height":"1478"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/445505233433016","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":855,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9056261960,"gmtCreate":1655021829950,"gmtModify":1676535549796,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Happy 8th Anniversary.I love Tiger as user friendly.Able me to trade in Singapore,Australia,Hongkong,China and US stock market.I am proud owning Tiger stocks too.Prosper together with Tiger.Love the Tiger coin as it becomes my daily routine to read news and accumulate the coins to offset some fees.Good trading platform.Cheers&nbsp;","listText":"Happy 8th Anniversary.I love Tiger as user friendly.Able me to trade in Singapore,Australia,Hongkong,China and US stock market.I am proud owning Tiger stocks too.Prosper together with Tiger.Love the Tiger coin as it becomes my daily routine to read news and accumulate the coins to offset some fees.Good trading platform.Cheers&nbsp;","text":"Happy 8th Anniversary.I love Tiger as user friendly.Able me to trade in Singapore,Australia,Hongkong,China and US stock market.I am proud owning Tiger stocks too.Prosper together with Tiger.Love the Tiger coin as it becomes my daily routine to read news and accumulate the coins to offset some fees.Good trading platform.Cheers","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":23,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9056261960","isVote":1,"tweetType":1,"viewCount":900,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4112405503246782","authorId":"4112405503246782","name":"pancherry","avatar":"https://community-static.tradeup.com/news/c89c54ad3676d7bcbe6f66034660aa21","crmLevel":12,"crmLevelSwitch":1,"authorIdStr":"4112405503246782","idStr":"4112405503246782"},"content":"all the best","text":"all the best","html":"all the best"},{"author":{"id":"3555293442593045","authorId":"3555293442593045","name":"Samlunch","avatar":"https://static.tigerbbs.com/17478579b111537e74aea4d338e8aef5","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3555293442593045","idStr":"3555293442593045"},"content":"Yes! And fractional shares too","text":"Yes! And fractional shares too","html":"Yes! And fractional shares too"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9096429880,"gmtCreate":1644451574384,"gmtModify":1676533927430,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Ready to take off","listText":"Ready to take off","text":"Ready to take off","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9096429880","repostId":"1154751327","repostType":4,"repost":{"id":"1154751327","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1644419033,"share":"https://ttm.financial/m/news/1154751327?lang=&edition=fundamental","pubTime":"2022-02-09 23:03","market":"us","language":"en","title":"Alibaba Shares Jumped over 3% in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1154751327","media":"Tiger Newspress","summary":"Alibaba Shares Jumped over 3% in Morning Trading. Softbank Said Additional Alibaba ADS Not Tied to A","content":"<html><head></head><body><p>Alibaba Shares Jumped over 3% in Morning Trading. Softbank Said Additional Alibaba ADS Not Tied to Any Specific Future Softbank Transaction.<img src=\"https://static.tigerbbs.com/ded43a9d79c85fd086b9d3d2dbcd926d\" tg-width=\"872\" tg-height=\"639\" referrerpolicy=\"no-referrer\"/>Alibaba&#39;s recent registration of additional American Depository Shares is not tied to any specific future transaction by SoftBank Group Corp, a spokesperson for the Japanese conglomerate said on Wednesday.</p><p>&#34;The registration of the ADR conversion facility (F6 filing, which was filed by Alibaba), including its size, is not tied to any specific future transaction by SBG,&#34; SoftBank said in a statement to Reuters.</p><p>E-commerce giant Alibaba last week filed to register an additional one billion American Depository Shares. The move, Citigroup analysts said this week, &#34;might also suggest potential selling intention by SoftBank.&#34;</p><p>&#34;Since Softbank has been a pre-IPO investor, we believe a large proportion of those shares have not been previously registered as ADS,&#34; Citi analysts including Alicia Yap wrote.</p><p>SoftBank&#39;s stake of around 25% in Alibaba is worth around $82 billion and has its origins in a $20 million investment in 2000. Alibaba&#39;s shares have fallen by 60% since highs in October 2020.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba Shares Jumped over 3% in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba Shares Jumped over 3% in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-09 23:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Alibaba Shares Jumped over 3% in Morning Trading. Softbank Said Additional Alibaba ADS Not Tied to Any Specific Future Softbank Transaction.<img src=\"https://static.tigerbbs.com/ded43a9d79c85fd086b9d3d2dbcd926d\" tg-width=\"872\" tg-height=\"639\" referrerpolicy=\"no-referrer\"/>Alibaba&#39;s recent registration of additional American Depository Shares is not tied to any specific future transaction by SoftBank Group Corp, a spokesperson for the Japanese conglomerate said on Wednesday.</p><p>&#34;The registration of the ADR conversion facility (F6 filing, which was filed by Alibaba), including its size, is not tied to any specific future transaction by SBG,&#34; SoftBank said in a statement to Reuters.</p><p>E-commerce giant Alibaba last week filed to register an additional one billion American Depository Shares. The move, Citigroup analysts said this week, &#34;might also suggest potential selling intention by SoftBank.&#34;</p><p>&#34;Since Softbank has been a pre-IPO investor, we believe a large proportion of those shares have not been previously registered as ADS,&#34; Citi analysts including Alicia Yap wrote.</p><p>SoftBank&#39;s stake of around 25% in Alibaba is worth around $82 billion and has its origins in a $20 million investment in 2000. Alibaba&#39;s shares have fallen by 60% since highs in October 2020.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154751327","content_text":"Alibaba Shares Jumped over 3% in Morning Trading. Softbank Said Additional Alibaba ADS Not Tied to Any Specific Future Softbank Transaction.Alibaba's recent registration of additional American Depository Shares is not tied to any specific future transaction by SoftBank Group Corp, a spokesperson for the Japanese conglomerate said on Wednesday.\"The registration of the ADR conversion facility (F6 filing, which was filed by Alibaba), including its size, is not tied to any specific future transaction by SBG,\" SoftBank said in a statement to Reuters.E-commerce giant Alibaba last week filed to register an additional one billion American Depository Shares. The move, Citigroup analysts said this week, \"might also suggest potential selling intention by SoftBank.\"\"Since Softbank has been a pre-IPO investor, we believe a large proportion of those shares have not been previously registered as ADS,\" Citi analysts including Alicia Yap wrote.SoftBank's stake of around 25% in Alibaba is worth around $82 billion and has its origins in a $20 million investment in 2000. Alibaba's shares have fallen by 60% since highs in October 2020.","news_type":1,"symbols_score_info":{"BABA":0.9}},"isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103729700,"gmtCreate":1619825317500,"gmtModify":1704335319673,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Go for Xpeng&nbsp;","listText":"Go for Xpeng&nbsp;","text":"Go for Xpeng","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":8,"repostSize":0,"link":"https://ttm.financial/post/103729700","repostId":"1137943982","repostType":4,"isVote":1,"tweetType":1,"viewCount":682,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3575326435298567","authorId":"3575326435298567","name":"Angsana","avatar":"https://static.tigerbbs.com/3c8492153d7059ec1aa704a1bd541c14","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3575326435298567","idStr":"3575326435298567"},"content":"NIO better lar haha","text":"NIO better lar haha","html":"NIO better lar haha"},{"author":{"id":"3574897713454581","authorId":"3574897713454581","name":"JCai","avatar":"https://static.tigerbbs.com/a4408059854d4abfa5d3e8513d447a16","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3574897713454581","idStr":"3574897713454581"},"content":"respond pls thanks!","text":"respond pls thanks!","html":"respond pls thanks!"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881448263,"gmtCreate":1631396669052,"gmtModify":1676530539266,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Yes,definitely is a good investment in these companies&nbsp;","listText":"Yes,definitely is a good investment in these companies&nbsp;","text":"Yes,definitely is a good investment in these companies","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/881448263","repostId":"2166375184","repostType":4,"isVote":1,"tweetType":1,"viewCount":467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812080029,"gmtCreate":1630541332261,"gmtModify":1676530333073,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Good sign&nbsp;","listText":"Good sign&nbsp;","text":"Good sign","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/812080029","repostId":"2164481914","repostType":4,"isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896047938,"gmtCreate":1628548683024,"gmtModify":1703507779074,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Unbelievable&nbsp;","listText":"Unbelievable&nbsp;","text":"Unbelievable","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/896047938","repostId":"1178202513","repostType":4,"isVote":1,"tweetType":1,"viewCount":351,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103905446,"gmtCreate":1619741594485,"gmtModify":1704271605263,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Only can stare at the share price","listText":"Only can stare at the share price","text":"Only can stare at the share price","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":9,"repostSize":0,"link":"https://ttm.financial/post/103905446","repostId":"1188611661","repostType":4,"repost":{"id":"1188611661","kind":"news","pubTimestamp":1619734487,"share":"https://ttm.financial/m/news/1188611661?lang=&edition=fundamental","pubTime":"2021-04-30 06:14","market":"us","language":"en","title":"Amazon sales surge 44% as it smashes earnings expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1188611661","media":"CNBC","summary":"Amazon released first-quarter results on Thursday that trounced analysts’ expectations.\nThe company ","content":"<ul>\n <li>Amazon released first-quarter results on Thursday that trounced analysts’ expectations.</li>\n <li>The company confirmed that this year’s Prime Day will take place in June, which will likely help year over year comparisons for revenue in the second quarter.</li>\n</ul>\n<p>Amazonshares climbed more than 3.5% in extended trading Thursday after the company&nbsp;released&nbsp;its first-quarter earnings, beating Wall Street’s expectations for earnings and revenue.</p>\n<p><img src=\"https://static.tigerbbs.com/798d7f0536203d2ae33b543f4dabf204\" tg-width=\"1281\" tg-height=\"591\"></p>\n<p>Here’s how the e-commerce giant fared, relative to analyst estimates compiled by Refinitiv:</p>\n<ul>\n <li><b>Earnings:</b>$15.79 per share vs. $9.54 per share expected</li>\n <li><b>Revenue:</b>$108.52 billion vs. $104.47 billion expected</li>\n</ul>\n<p>Few companies have benefited from the pandemic-fueled surge of online shoppingas much as Amazon. Its first-quarter results showed the company’s business continues to be buoyed by the pandemic, with sales soaring 44% year-over-year to $108.5 billion.</p>\n<p>Amazon’s guidance for the second quarter implies that it expects the momentum to continue, which should help allay investor fears that business could slow in a post-pandemic environment. The company expects to post revenue between $110 billion and $116 billion, surpassing Wall Street’s projection $108.6 billion.</p>\n<p>Crucially, Amazon confirmed in its guidance that this year’s Prime Day will take place in June, which will likely help year-over-year comparisons for revenue in the second quarter. Typically, Amazon’s annual, two-day discount bonanza takes place in July, but the company postponed the event to October last year amid pandemic-related uncertainty.</p>\n<p>When asked about the Prime Day timing, CFO Brian Olsavsky said on a call with investors: “In many areas, July is vacation month, so it might be better for customers, sellers and vendors to experiment with a different time period. We believe that it might be better timing later in [the second quarter], so that’s what we’re testing this year.”</p>\n<p>Outside of its core retail segment, Amazon’s cloud-computing and advertising businesses continue to boom. Amazon Web Servicessawnet sales of $13.5 billion during the quarter, up 32% year over year. Amazon doesn’t disclose advertising sales, but it’s included in the company’s “Other” category, which saw its revenues grow 77% year over year to $6.9 billion.</p>\n<p>Amazon CEO Jeff Bezos also gave a rare glimpse into how the company’s streaming business has fared during the pandemic, as stuck-at-home consumers relied on online entertainment to keep busy. “As Prime Video turns 10, over 175 million Prime members have streamed shows and movies in the past year, and streaming hours are up more than 70% year over year,” he said.</p>\n<p>Amazon’s streaming service, Prime Video, is a key offering of the company’s Prime subscription service, which costs $119 a year and includes a range of other benefits like free, two-day shipping. Bezos disclosed earlier this month that the company now has 200 million Prime subscribers, 50 million more than it had at the start of 2020.</p>\n<p>Physical stores revenue, which includes Whole Foods Market and other brick-and-mortar offerings like Amazon Books, continued to fall. Sales slumped 16% to $3.9 billion. The category excludes online delivery, Olsavsky said.</p>\n<p>During the quarter, Amazon’s sales grew faster internationally than they did in North America. International revenue surged 60% year over year, more than any other segment, while North America revenue climbed 40%.</p>\n<p>As expected, Amazon will incur fewer costs this year related to coronavirus safety measures. Operating income is forecast to be between $4.5 billion and $8 billion in the second quarter, assuming $1.5 billion of costs related to Covid-19. That’s in line with what Amazon executives predicted last quarter.</p>\n<p>AmazonsaidWednesday it would spend more than $1 billion on raising wages for over half a million of its U.S. operations workers. On a call with reporters, Olsavsky said it decided to move up the pay increase from the fall to this spring as volumes remain just as strong as they were at the beginning of the pandemic.</p>\n<p>Olsavsky declined to comment on Amazon’s CEO transition plans, which will come into play once Bezossteps down in the third quarter. Bezos will turn the helm over to AWS CEO Andy Jassy and assume the role of executive chairman of Amazon’s board.</p>","source":"lsy1609915699154","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon sales surge 44% as it smashes earnings expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon sales surge 44% as it smashes earnings expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 06:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/29/amazon-amzn-earnings-q1-2021.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amazon released first-quarter results on Thursday that trounced analysts’ expectations.\nThe company confirmed that this year’s Prime Day will take place in June, which will likely help year over year ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/29/amazon-amzn-earnings-q1-2021.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.cnbc.com/2021/04/29/amazon-amzn-earnings-q1-2021.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188611661","content_text":"Amazon released first-quarter results on Thursday that trounced analysts’ expectations.\nThe company confirmed that this year’s Prime Day will take place in June, which will likely help year over year comparisons for revenue in the second quarter.\n\nAmazonshares climbed more than 3.5% in extended trading Thursday after the company released its first-quarter earnings, beating Wall Street’s expectations for earnings and revenue.\n\nHere’s how the e-commerce giant fared, relative to analyst estimates compiled by Refinitiv:\n\nEarnings:$15.79 per share vs. $9.54 per share expected\nRevenue:$108.52 billion vs. $104.47 billion expected\n\nFew companies have benefited from the pandemic-fueled surge of online shoppingas much as Amazon. Its first-quarter results showed the company’s business continues to be buoyed by the pandemic, with sales soaring 44% year-over-year to $108.5 billion.\nAmazon’s guidance for the second quarter implies that it expects the momentum to continue, which should help allay investor fears that business could slow in a post-pandemic environment. The company expects to post revenue between $110 billion and $116 billion, surpassing Wall Street’s projection $108.6 billion.\nCrucially, Amazon confirmed in its guidance that this year’s Prime Day will take place in June, which will likely help year-over-year comparisons for revenue in the second quarter. Typically, Amazon’s annual, two-day discount bonanza takes place in July, but the company postponed the event to October last year amid pandemic-related uncertainty.\nWhen asked about the Prime Day timing, CFO Brian Olsavsky said on a call with investors: “In many areas, July is vacation month, so it might be better for customers, sellers and vendors to experiment with a different time period. We believe that it might be better timing later in [the second quarter], so that’s what we’re testing this year.”\nOutside of its core retail segment, Amazon’s cloud-computing and advertising businesses continue to boom. Amazon Web Servicessawnet sales of $13.5 billion during the quarter, up 32% year over year. Amazon doesn’t disclose advertising sales, but it’s included in the company’s “Other” category, which saw its revenues grow 77% year over year to $6.9 billion.\nAmazon CEO Jeff Bezos also gave a rare glimpse into how the company’s streaming business has fared during the pandemic, as stuck-at-home consumers relied on online entertainment to keep busy. “As Prime Video turns 10, over 175 million Prime members have streamed shows and movies in the past year, and streaming hours are up more than 70% year over year,” he said.\nAmazon’s streaming service, Prime Video, is a key offering of the company’s Prime subscription service, which costs $119 a year and includes a range of other benefits like free, two-day shipping. Bezos disclosed earlier this month that the company now has 200 million Prime subscribers, 50 million more than it had at the start of 2020.\nPhysical stores revenue, which includes Whole Foods Market and other brick-and-mortar offerings like Amazon Books, continued to fall. Sales slumped 16% to $3.9 billion. The category excludes online delivery, Olsavsky said.\nDuring the quarter, Amazon’s sales grew faster internationally than they did in North America. International revenue surged 60% year over year, more than any other segment, while North America revenue climbed 40%.\nAs expected, Amazon will incur fewer costs this year related to coronavirus safety measures. Operating income is forecast to be between $4.5 billion and $8 billion in the second quarter, assuming $1.5 billion of costs related to Covid-19. That’s in line with what Amazon executives predicted last quarter.\nAmazonsaidWednesday it would spend more than $1 billion on raising wages for over half a million of its U.S. operations workers. On a call with reporters, Olsavsky said it decided to move up the pay increase from the fall to this spring as volumes remain just as strong as they were at the beginning of the pandemic.\nOlsavsky declined to comment on Amazon’s CEO transition plans, which will come into play once Bezossteps down in the third quarter. Bezos will turn the helm over to AWS CEO Andy Jassy and assume the role of executive chairman of Amazon’s board.","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":492,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578111487107537","authorId":"3578111487107537","name":"Chimpsey","avatar":"https://static.tigerbbs.com/ab58cb989ba2205bb2646f1c4d97c579","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3578111487107537","idStr":"3578111487107537"},"content":"Already so high","text":"Already so high","html":"Already so high"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860612239,"gmtCreate":1632175341921,"gmtModify":1676530715590,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Getting ready and trade safely&nbsp;","listText":"Getting ready and trade safely&nbsp;","text":"Getting ready and trade safely","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/860612239","repostId":"1124728794","repostType":4,"repost":{"id":"1124728794","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632154404,"share":"https://ttm.financial/m/news/1124728794?lang=&edition=fundamental","pubTime":"2021-09-21 00:13","market":"us","language":"en","title":"Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124728794","media":"Tiger Newspress","summary":"(Sept 21)&nbsp;Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%.","content":"<p>(Sept 21)&nbsp;Market sell-off worsens with Dow dropping 650 points, S&amp;P 500 losing 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/b1aff42b5f28f13e23dc15c6bee909d3\" tg-width=\"350\" tg-height=\"130\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-21 00:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 21)&nbsp;Market sell-off worsens with Dow dropping 650 points, S&amp;P 500 losing 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/b1aff42b5f28f13e23dc15c6bee909d3\" tg-width=\"350\" tg-height=\"130\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124728794","content_text":"(Sept 21) Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":626,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836268788,"gmtCreate":1629501599244,"gmtModify":1676530058088,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Stay invested&nbsp;","listText":"Stay invested&nbsp;","text":"Stay invested","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/836268788","repostId":"2161743232","repostType":4,"repost":{"id":"2161743232","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629489634,"share":"https://ttm.financial/m/news/2161743232?lang=&edition=fundamental","pubTime":"2021-08-21 04:00","market":"us","language":"en","title":"Wall Street rallies as Fed jitters ease, but posts weekly loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2161743232","media":"Reuters","summary":"NEW YORK, Aug 20 (Reuters) - Wall Street rallied to close sharply higher at the close of a tumultuou","content":"<p>NEW YORK, Aug 20 (Reuters) - Wall Street rallied to close sharply higher at the close of a tumultuous week on waning concerns over whether the U.S. Federal Reserve could begin tightening its dovish monetary policy sooner than expected.</p>\n<p>While all three major U.S. indexes ended solidly green, all posted weekly losses after a steep mid-week sell-off pulled the S&amp;P 500 and the Dow away from a string of record closing highs.</p>\n<p>\"Towards the beginning of the week you saw traders balancing their books ahead of the Fed statement,\" said Matthew Keator, managing partner in the Keator Group, a wealth management firm in Lenox, Massachusetts. \"And once the statement came out, you saw a bit of 'sell the rumor buy the news.'\"</p>\n<p>Market-leading tech and tech-adjacent megacaps, which weathered the pandemic recession better than most, once again provided the biggest boost.</p>\n<p>Growth stocks were also given a boost by U.S. Treasury yields, which ended the week lower due to concerns the health crisis could be a longer than expected hindrance to economic revival.</p>\n<p>Announcements from a host of Asian nations that they are implementing drastic measures to curb the resurgence of COVID-19 due to the rise of the disease's highly contagious Delta variant, put a damper on stocks associated with economic re-engagement.</p>\n<p>Mixed economic data from the U.S. and China suggested the ongoing recovery from the most abrupt recession on record has passed its peak and lost some momentum.</p>\n<p>Market participants now look to next week's Jackson Hole Symposium, a gathering of major central bank leaders, for clues from Fed Chair Jerome Powell regarding the expected pace of recovery and the timeline for policy tightening.</p>\n<p>\"We’ve seen times in history where the Jackson Hole Symposium has drawn a lot of eyeballs but this year more so,\" Keator added. \"The Fed might use this opportunity to communicate what their plan is going forward.\"</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 222.15 points, or 0.64%, to 35,116.27, the S&amp;P 500 gained 35.79 points, or 0.81%, to 4,441.59 and the Nasdaq Composite&nbsp;added 169.95 points, or 1.17%, to 14,711.73.</p>\n<p>All 11 major sectors of the S&amp;P 500 ended the session higher.</p>\n<p>Second-quarter reporting season has essentially run its course, with 476 of the companies in the S&amp;P 500 having posted results. Of those, 87.4% have beaten consensus, according to Refinitiv data.</p>\n<p>Farm and construction equipment manufacturer Deere &amp; Co&nbsp;beat quarterly profit expectations and raised its full year guidance due to robust demand . Still, its shares lost ground.</p>\n<p>Bristol-Myers Squibb advanced after the U.S. Food and Drug Administration approved the drugmaker's cancer drug Opdivo.</p>\n<p>U.S.-listed shares of China-based tech-related companies oscillated as market participants digested recent sell-offs resulting from Beijing's ongoing regulatory crackdown, which has wiped half a trillion dollars from Chinese markets this week.</p>\n<p>(Reporting by Stephen Culp; Additional reporting by Devik Jain and Medha Singh in Bengaluru; Editing by Aurora Ellis)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street rallies as Fed jitters ease, but posts weekly loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street rallies as Fed jitters ease, but posts weekly loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-21 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Aug 20 (Reuters) - Wall Street rallied to close sharply higher at the close of a tumultuous week on waning concerns over whether the U.S. Federal Reserve could begin tightening its dovish monetary policy sooner than expected.</p>\n<p>While all three major U.S. indexes ended solidly green, all posted weekly losses after a steep mid-week sell-off pulled the S&amp;P 500 and the Dow away from a string of record closing highs.</p>\n<p>\"Towards the beginning of the week you saw traders balancing their books ahead of the Fed statement,\" said Matthew Keator, managing partner in the Keator Group, a wealth management firm in Lenox, Massachusetts. \"And once the statement came out, you saw a bit of 'sell the rumor buy the news.'\"</p>\n<p>Market-leading tech and tech-adjacent megacaps, which weathered the pandemic recession better than most, once again provided the biggest boost.</p>\n<p>Growth stocks were also given a boost by U.S. Treasury yields, which ended the week lower due to concerns the health crisis could be a longer than expected hindrance to economic revival.</p>\n<p>Announcements from a host of Asian nations that they are implementing drastic measures to curb the resurgence of COVID-19 due to the rise of the disease's highly contagious Delta variant, put a damper on stocks associated with economic re-engagement.</p>\n<p>Mixed economic data from the U.S. and China suggested the ongoing recovery from the most abrupt recession on record has passed its peak and lost some momentum.</p>\n<p>Market participants now look to next week's Jackson Hole Symposium, a gathering of major central bank leaders, for clues from Fed Chair Jerome Powell regarding the expected pace of recovery and the timeline for policy tightening.</p>\n<p>\"We’ve seen times in history where the Jackson Hole Symposium has drawn a lot of eyeballs but this year more so,\" Keator added. \"The Fed might use this opportunity to communicate what their plan is going forward.\"</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 222.15 points, or 0.64%, to 35,116.27, the S&amp;P 500 gained 35.79 points, or 0.81%, to 4,441.59 and the Nasdaq Composite&nbsp;added 169.95 points, or 1.17%, to 14,711.73.</p>\n<p>All 11 major sectors of the S&amp;P 500 ended the session higher.</p>\n<p>Second-quarter reporting season has essentially run its course, with 476 of the companies in the S&amp;P 500 having posted results. Of those, 87.4% have beaten consensus, according to Refinitiv data.</p>\n<p>Farm and construction equipment manufacturer Deere &amp; Co&nbsp;beat quarterly profit expectations and raised its full year guidance due to robust demand . Still, its shares lost ground.</p>\n<p>Bristol-Myers Squibb advanced after the U.S. Food and Drug Administration approved the drugmaker's cancer drug Opdivo.</p>\n<p>U.S.-listed shares of China-based tech-related companies oscillated as market participants digested recent sell-offs resulting from Beijing's ongoing regulatory crackdown, which has wiped half a trillion dollars from Chinese markets this week.</p>\n<p>(Reporting by Stephen Culp; Additional reporting by Devik Jain and Medha Singh in Bengaluru; Editing by Aurora Ellis)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF",".SPX":"S&P 500 Index","SPXU":"三倍做空标普500ETF-ProShares","SH":"做空标普500-Proshares","DOG":"道指ETF-ProShares做空","PSQ":"做空纳斯达克100指数ETF-ProShares","SSO":"2倍做多标普500ETF-ProShares",".IXIC":"NASDAQ Composite","TQQQ":"纳指三倍做多ETF","IVV":"标普500ETF-iShares","QQQ":"纳指100ETF","OEX":"标普100",".DJI":"道琼斯","SDOW":"三倍做空道指30ETF-ProShares","QLD":"2倍做多纳斯达克100指数ETF-ProShares","SDS":"两倍做空标普500 ETF-ProShares","DJX":"1/100道琼斯","UDOW":"三倍做多道指30ETF-ProShares","QID":"两倍做空纳斯达克指数ETF-ProShares","UPRO":"三倍做多标普500ETF-ProShares","SQQQ":"纳指三倍做空ETF","OEF":"标普100指数ETF-iShares","DDM":"2倍做多道指ETF-ProShares","DXD":"两倍做空道琼30指数ETF-ProShares"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161743232","content_text":"NEW YORK, Aug 20 (Reuters) - Wall Street rallied to close sharply higher at the close of a tumultuous week on waning concerns over whether the U.S. Federal Reserve could begin tightening its dovish monetary policy sooner than expected.\nWhile all three major U.S. indexes ended solidly green, all posted weekly losses after a steep mid-week sell-off pulled the S&P 500 and the Dow away from a string of record closing highs.\n\"Towards the beginning of the week you saw traders balancing their books ahead of the Fed statement,\" said Matthew Keator, managing partner in the Keator Group, a wealth management firm in Lenox, Massachusetts. \"And once the statement came out, you saw a bit of 'sell the rumor buy the news.'\"\nMarket-leading tech and tech-adjacent megacaps, which weathered the pandemic recession better than most, once again provided the biggest boost.\nGrowth stocks were also given a boost by U.S. Treasury yields, which ended the week lower due to concerns the health crisis could be a longer than expected hindrance to economic revival.\nAnnouncements from a host of Asian nations that they are implementing drastic measures to curb the resurgence of COVID-19 due to the rise of the disease's highly contagious Delta variant, put a damper on stocks associated with economic re-engagement.\nMixed economic data from the U.S. and China suggested the ongoing recovery from the most abrupt recession on record has passed its peak and lost some momentum.\nMarket participants now look to next week's Jackson Hole Symposium, a gathering of major central bank leaders, for clues from Fed Chair Jerome Powell regarding the expected pace of recovery and the timeline for policy tightening.\n\"We’ve seen times in history where the Jackson Hole Symposium has drawn a lot of eyeballs but this year more so,\" Keator added. \"The Fed might use this opportunity to communicate what their plan is going forward.\"\nUnofficially, the Dow Jones Industrial Average rose 222.15 points, or 0.64%, to 35,116.27, the S&P 500 gained 35.79 points, or 0.81%, to 4,441.59 and the Nasdaq Composite added 169.95 points, or 1.17%, to 14,711.73.\nAll 11 major sectors of the S&P 500 ended the session higher.\nSecond-quarter reporting season has essentially run its course, with 476 of the companies in the S&P 500 having posted results. Of those, 87.4% have beaten consensus, according to Refinitiv data.\nFarm and construction equipment manufacturer Deere & Co beat quarterly profit expectations and raised its full year guidance due to robust demand . Still, its shares lost ground.\nBristol-Myers Squibb advanced after the U.S. Food and Drug Administration approved the drugmaker's cancer drug Opdivo.\nU.S.-listed shares of China-based tech-related companies oscillated as market participants digested recent sell-offs resulting from Beijing's ongoing regulatory crackdown, which has wiped half a trillion dollars from Chinese markets this week.\n(Reporting by Stephen Culp; Additional reporting by Devik Jain and Medha Singh in Bengaluru; Editing by Aurora Ellis)","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,"SDOW":0.9,"PSQ":0.9,"SPXU":0.9,"QQQ":0.9,".IXIC":0.9,"SSO":0.9,"SQQQ":0.9,".DJI":0.9,"UDOW":0.9,"TQQQ":0.9,"ESmain":0.9,"IVV":0.9,"SH":0.9,"QID":0.9,"MNQmain":0.9,"NQmain":0.9,"DDM":0.9,"OEX":0.9,"SDS":0.9,".SPX":0.9,"DOG":0.9,"UPRO":0.9,"DXD":0.9,"DJX":0.9,"QLD":0.9,"OEF":0.9}},"isVote":1,"tweetType":1,"viewCount":536,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3553658931361428","authorId":"3553658931361428","name":"yaozong7","avatar":"https://community-static.tradeup.com/news/0db82c58fe151c6056334e54bf8ceeee","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3553658931361428","idStr":"3553658931361428"},"content":"Always! But in ETFs.","text":"Always! But in ETFs.","html":"Always! But in ETFs."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180838308,"gmtCreate":1623197712904,"gmtModify":1704198036590,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Not in bitcoin","listText":"Not in bitcoin","text":"Not in bitcoin","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/180838308","repostId":"1160645804","repostType":4,"isVote":1,"tweetType":1,"viewCount":827,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":476208223433544,"gmtCreate":1757289096158,"gmtModify":1757296499895,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/600276\">$Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/600276\">$Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$</a>&nbsp;","text":"$Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$","images":[{"img":"https://community-static.tradeup.com/news/0ad5f6a1cee5b95385d092aae759fdee","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/476208223433544","isVote":1,"tweetType":1,"viewCount":988,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9011714268,"gmtCreate":1648938408687,"gmtModify":1676534422968,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Great to own them","listText":"Great to own them","text":"Great to own them","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9011714268","repostId":"1123130739","repostType":4,"repost":{"id":"1123130739","kind":"news","pubTimestamp":1648865521,"share":"https://ttm.financial/m/news/1123130739?lang=&edition=fundamental","pubTime":"2022-04-02 10:12","market":"us","language":"en","title":"7 Blue-Chip Stocks to Buy for April 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1123130739","media":"InvestorPlace","summary":"Nike: Best-of-breed apparel maker and a leader in sports apparel.Alphabet (GOOGL, GOOG): Owns the to","content":"<div>\n<p>Nike: Best-of-breed apparel maker and a leader in sports apparel.Alphabet (GOOGL, GOOG): Owns the top two websites in the world.Apple: Unrivaled business model with its Products and Services ...</p>\n\n<a href=\"https://investorplace.com/2022/04/7-blue-chip-stocks-to-buy-for-april-2022/\">Web Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Blue-Chip Stocks to Buy for April 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Blue-Chip Stocks to Buy for April 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-02 10:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/04/7-blue-chip-stocks-to-buy-for-april-2022/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nike: Best-of-breed apparel maker and a leader in sports apparel.Alphabet (GOOGL, GOOG): Owns the top two websites in the world.Apple: Unrivaled business model with its Products and Services ...</p>\n\n<a href=\"https://investorplace.com/2022/04/7-blue-chip-stocks-to-buy-for-april-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","NVDA":"英伟达","V":"Visa","MA":"万事达","NKE":"耐克","GOOGL":"谷歌A","SBUX":"星巴克","AAPL":"苹果"},"source_url":"https://investorplace.com/2022/04/7-blue-chip-stocks-to-buy-for-april-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123130739","content_text":"Nike: Best-of-breed apparel maker and a leader in sports apparel.Alphabet (GOOGL, GOOG): Owns the top two websites in the world.Apple: Unrivaled business model with its Products and Services businesses.Visa: Runs a near-duopoly on the credit card market.MasterCard: Like Visa, operates with impressive margins and cash flow.Nvidia: Best-of-breed tech juggernaut catering to multiple end-markets enjoying strong secular growth.Starbucks: A leader in the consumer/retail business and has a strong focus on shareholder returns.Early in my investing career, I saw something that really piqued my interest: blue-chip stocks. But not just blue-chip stocks of that era. Instead, I was after future blue chips; And thus, the Future Blue Chips idea had dawned on me.Since then, I have been hunting tomorrow’s shining stars of today, sniffing out the best stocks I can find with strong fundamentals, solid leadership and reasonable valuations.These are long-term, theme-oriented stocks that are relying on high-quality businesses and secular trends. Years ago — perhaps a decade — I would get people that would reach out to me and say, “Hey! These are already well-known companies. Find something new, would ya!”Well, it’s hard to be a future blue chips stock if the company isn’t already a good one. At the time, it included many of the names you see above, minus Nvidia unfortunately. On the plus side, the rest of these companies have continued to deliver the goods. And now, we’re going to go one-by-one through them to see why.Blue-Chip Stocks to Buy: NikeSource: TY Lim / Shutterstock.comOne of the largest apparel companies in the world isNike(NYSE:NKE). It operates a wonderful blend between being a wholesale apparel maker and a high-end athletic retailer. By running its own locations, as well as selling to other retailers, Nike diversifies its revenue and is able to drive incremental margin growth to its bottom line.In a nutshell, it can drive sales at its own locations, while relying on the size of other retailers to generate revenue. But Nike’s real crown jewel is its direct-to-consumer (DTC) business.Referred to by the company as its DTC unit, this business is what allows Nike to drive significant margin expansion. It’s also what allowed the company to recover more quickly than most apparel makers and apparel retailers in the early days of the novel coronavirus pandemic.With its DTC business, Nike can sell right to its customers. In turn, that allows it to build better analytics and improve its target marketing. It also allows it to cut out the middleman. Last quarter,overall revenue increased 4.9%year-over-year (YOY). However, its DTC business climbed 17% on a currency-neutral basis. So, clearly, that’s where the momentum is at.Alphabet (GOOG, GOOGL)Source: rvlsoft / Shutterstock.comAlphabet (GOOGL, GOOG) is one of the best companies in the entire market, and there are three simple reasons why: Assets, growth and its balance sheet. Let’s go in that order.The company commands a market capitalization of about $1.9 trillion, so of course, it has many assets. However, its main assets are Google.com and YouTube.com. Not only are these the two most popular websites in the world — akin to owning Boardwalk and Park Place in the gameMonopoly — but they also boast strong growth.That leads us to our second point. In combination with its cloud unit and other divisions, Alphabet continues to churn out impressive growth. Last quarter, revenue climbedmore than 32% YOY. This year, analysts expectsales growth of 16.7%. And for 2023, those estimates sit at 15.6%. Meanwhile, earnings growth forecasts are similar.When it comes to free cash flow, Alphabet generated $67billioninFCF last year. That was up more than 55% from the prior year, while this figure grew more than 35% in each of the prior two years as well.All of this growth is doing just one thing, which is growing the balance sheet. As of its latest quarter, Alphabet has $188 billion in current assets, almost $140 billion of which are in cash and short-term securities. The company also carries $14.8 billion in long-term debt, or a quarter of that when we exclude capitalized leases.Blue-Chip Stocks to Buy: Apple Source: WeDesing / Shutterstock.comI refer to Apple  as having one of the best business models in the world. It runs the razor/razor blade model, but at an incredible premium.The razor/razor blade model is premised on the idea of getting the razor into customer’s hands — even if that means giving it away at cost (or less) — so that they will continue to buy razors from you, which is the real money maker.Rather than give away its razors though — in this case, that’s iPhones, iPads, Macs, etc. — Apple charges a hefty premium. They mark these devices up in price to the point where they alone generate an enormous business for Apple.So, what then is the razor blade portion of the business? Services.Last quarter, overall revenue grew 11%, whileServicesrevenuegrew almost 24%YOY. Not only is it outpacing the company’s Products revenue in terms of growth, and overall revenue growth, but Apple’s Services unit is more than twice as profitable as its Products business. And that is the main catalyst that people need to understand.Visa Source: Kikinunchi / Shutterstock.comOutside of the tech space, these next two companies have been some of the best performers over the last decade. Visa and MasterCard run what I like to call a “toll booth” on transactions.There’s a secular trend that’s been underway for years, as consumers transition from cash and check to credit and debit. Additionally, the rise of online and digital sales has only fueled this move, as consumers obviously find it easy to shop.Specifically, with these two businesses, investors have been quick to critique the valuation by pointing out that Visa stock trades at more than 17 times its trailing 12-month revenue. In the past, this valuation has also been an issue.Even during generous market periods, that’s a rich valuation for many growth stocks.However, in those instances, investors aren’t taking profits into account for the growth stocks, because many don’t have any. And in the case of Visa, it’s incredibly profitable.Overall, the company sports gross profit margins of almost 80% and net profit margins of 51.6%. These metrics aren’t back to the pre-pandemic highs just yet, but they are inching in that direction now. Therefore, it makes a great option among the top blue-chip stocks to buy.Blue-Chip Stocks to Buy: MasterCard Source: Alexander Yakimov / Shutterstock.comMasterCard is very similar to Visa. Like the latter, MasterCard also tends to trade at a high price-sales (P/S) ratio. While many will glance at this metric and dismiss these stocks, it’s a foolish way to evaluate them. Admittedly the valuations have crept higher, but from this standpoint, they have almost always been elevated. And yet, investors have reaped enormous rewards by staying long Visa and MasterCard.In fact, 76% of revenue is converted into gross profit and almost half of revenue falls to the bottom line. In turn, MasterCard boasts a net profit margin of 46%. Of course, like Visa, these margins are not back to pre-pandemic levels; But they do continue to climb.Collectively, the major risk to these businesses isn’t digital sales, cryptocurrencies or otherwise. It’s a recession, either globally or domestically. Lower consumer spending will be a big net negative to these stocks specifically since spending is what drives the top and bottom line.NvidiaSource: Hairem / Shutterstock.comAs one of the greatest companies in the market as well, Nvidia caters to multiple end-markets that are enjoying long-term secular growth. Some of those end markets include:Datacenter, cloud computing, supercomputing, artificial intelligence and machine learning, graphics, gaming, autonomous driving and automotive, drones, robotics, the metaverse and more.Moreover, when you look at those markets, it’s pretty clear to see the trends. Do customers want faster computers, better graphics, and more responsive gaming and control (for drones, robotics, autonomous driving)? Do they want faster cloud-based applications and are they generating more data?The answers to these questions all point to more demand for Nvidia’s products In turn, it’s the main reason I believe this firm will eventually command a $1 trillion market cap.Blue-Chip Stocks to Buy: Starbucks Source: Grand Warszawski / Shutterstock.comLast but not least, we have a dominant food- and drinks-based retailer with Starbucks. Aside from routinely landing among the top spots in thePiper Sandlerteen survey, Starbucks remains a go-to “third place” for consumers of all ages.The company may be out of its strong growth days, but Starbucks still generates impressive cash flow and growth. With that in mind, analysts expectabout 13% revenue growth this year, then a steady 8% to 9% growth ineach of the next three years.On the earnings front, analysts expect roughly 18% earnings growth this year, followed by more than 17% growth next year.Furthermore, the recent dip in the stock has driven Starbucks’ dividend yield up above 2%.While it’s not winning many income investors over at that rate, it’s not bad for those of us with a long-term horizon that isn’t necessarily focused solely on dividend income. However, the company has made this yield a priority.Starbucks has grown its dividend for 11 years now, with afive-year average growth rateof about 15.9%. So, clearly, it’s a focus.Thus, as long as the world is drinking coffee, Starbucks will be a winner.","news_type":1,"symbols_score_info":{"AAPL":0.9,"SBUX":0.9,"MA":0.9,"GOOG":0.9,"NKE":0.9,"NVDA":0.9,"V":0.9,"GOOGL":0.9}},"isVote":1,"tweetType":1,"viewCount":750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9039625484,"gmtCreate":1646025515759,"gmtModify":1676534083511,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"This is a good bet🤣","listText":"This is a good bet🤣","text":"This is a good bet🤣","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039625484","repostId":"2214189884","repostType":4,"isVote":1,"tweetType":1,"viewCount":983,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003001161,"gmtCreate":1640820856749,"gmtModify":1676533543861,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003001161","repostId":"2195466435","repostType":4,"isVote":1,"tweetType":1,"viewCount":577,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3566385558470298","authorId":"3566385558470298","name":"___ _","avatar":"https://community-static.tradeup.com/news/e0600059befbdbcd780f0d15118a44d6","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3566385558470298","idStr":"3566385558470298"},"content":"Wishing you a Prosperity and Great returns for 2022 🙆‍♀️ Happy New Year to you and family 🦋","text":"Wishing you a Prosperity and Great returns for 2022 🙆‍♀️ Happy New Year to you and family 🦋","html":"Wishing you a Prosperity and Great returns for 2022 🙆‍♀️ Happy New Year to you and family 🦋"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863737899,"gmtCreate":1632435360911,"gmtModify":1676530779934,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/863737899","repostId":"1159478468","repostType":4,"repost":{"id":"1159478468","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632411695,"share":"https://ttm.financial/m/news/1159478468?lang=&edition=fundamental","pubTime":"2021-09-23 23:41","market":"other","language":"en","title":"EngageSmart opens for trading at $37, up about 43.6% from IPO price","url":"https://stock-news.laohu8.com/highlight/detail?id=1159478468","media":"Tiger Newspress","summary":"(Sept 23) EngageSmart Inc. opens for trading at $37, up about 43.6% from IPO price.\n\nCompany\nBraintr","content":"<p>(Sept 23)&nbsp;<a href=\"https://laohu8.com/S/ESMT\">EngageSmart Inc.</a> opens for trading at $37, up about 43.6% from IPO price.</p>\n<p><img src=\"https://static.tigerbbs.com/835bc9b4ff09e761852f27f75743b887\" tg-width=\"898\" tg-height=\"550\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Company</b></p>\n<p>Braintree, Massachusetts-based EngageSmart was founded to develop a platform that improves customer engagement tailored for certain industry verticals.</p>\n<p>Management is headed by founder and CEO Robert P. Bennett, who has been with the firm since inception and was previously president of Sage Payment Solutions.</p>\n<p>The company's primary offerings include:</p>\n<ul>\n <li>SimplePractice - Wellness</li>\n <li>InvoiceCloud - Government, Utilities and Financial Services</li>\n <li>HealthPay24 - Healthcare</li>\n <li>DonorDrive - Non-profit and Corporate Fundraising</li>\n</ul>\n<p>EngageSmart has received at least $451 million in equity investment from investors including General Atlantic and Summit Partners.</p>\n<p><b>Customer Acquisition</b></p>\n<p>The firm pursues both large enterprise customers and SMB customers via its direct sales force and online service.</p>\n<p>As of June 30, 2021, the firm had served over 68,000 clients in the SMB market and more than 3,000 customers in its Enterprise Solutions segment.</p>\n<p>Selling and Marketing expenses as a percentage of total revenue have dropped as revenues have increased, as the figures below indicate:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling and Marketing</b></p></td>\n   <td><p><b>Expenses vs. Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Percentage</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>32.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>33.1%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>43.1%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The Selling and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling and Marketing spend, dropped slightly to 1.1x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling and Marketing</b></p></td>\n   <td><p><b>Efficiency Rate</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Multiple</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>1.1</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>1.3</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The Rule of 40 is a software industry rule of thumb that says that as long as the combined revenue growth rate and EBITDA percentage rate equal or exceed 40%, the firm is on an acceptable growth/EBITDA trajectory.</p>\n<p>ESMT's most recent calculation was 64% as of June 30, 2021, so the firm is performing well in this regard, per the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Rule of 40</b></p></td>\n   <td><p><b>Calculation</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Recent Rev. Growth %</p></td>\n   <td><p>59%</p></td>\n  </tr>\n  <tr>\n   <td><p>EBITDA %</p></td>\n   <td><p>5%</p></td>\n  </tr>\n  <tr>\n   <td><p>Total</p></td>\n   <td><p>64%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The firm's dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.</p>\n<p>The dollar-based net revenue retention rate metric measures how much additional revenue is generated over time from each cohort of customers, so that a figure over 100% means that the company is generating more revenue from the same customer cohort over time, indicating good product/market fit and efficient sales and marketing efforts.</p>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2021 marketresearch reportby Mordor Intelligence, the global market for customer engagement solutions was an estimated $15.5 billion in 2020 and is forecast to reach $30.9 billion by 2026.</p>\n<p>This represents a forecast CAGR of 12.65% from 2021 to 2026.</p>\n<p>The main drivers for this expected growth are a growth in technology solutions to improve the customer journey via any device they use to connect with businesses.</p>\n<p>Also, a desire to reduce customer churn rate results in improved business financials and growing valuation.</p>\n<p>Below is a chart showing the variation in customer churn rates in different industries in the U.S. in 2018:</p>\n<p><img src=\"https://static.tigerbbs.com/f1066adb602d05e4e99630aacf61e1c5\" tg-width=\"1060\" tg-height=\"922\" referrerpolicy=\"no-referrer\">Major competitive or other industry participants include:</p>\n<ul>\n <li><p>IBM(NYSE:IBM)</p></li>\n <li><p>Microsoft(NASDAQ:MSFT)</p></li>\n <li><p>Nuance(NASDAQ:NUAN)</p></li>\n <li><p>Oracle(NYSE:ORCL)</p></li>\n <li><p>Salesforce(NYSE:CRM)</p></li>\n <li><p>Avaya(NYSE:AVYA)</p></li>\n <li><p>Calabrio</p></li>\n <li><p>Aspect Software</p></li>\n <li><p>Genesys</p></li>\n <li><p>Verint Systems(NASDAQ:VRNT)</p></li>\n <li><p>NICE Ltd.(NASDAQ:NICE)</p></li>\n <li><p>OpenText</p></li>\n <li><p>Pegasystems(NASDAQ:PEGA)</p></li>\n <li><p>Others</p></li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>EngageSmart's recent financial results can be summarized as follows:</p>\n<ul>\n <li><p>Growing topline revenue</p></li>\n <li><p>Increasing gross profit and high gross margin</p></li>\n <li><p>Growing operating profit and net income</p></li>\n <li><p>Increasing cash flow from operations</p></li>\n</ul>\n<p>Below are relevant financial results derived from the firm's registration statement:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Total Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Total Revenue</p></td>\n   <td><p>% Variance vs. Prior</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 99,171,000</p></td>\n   <td><p>58.6%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 146,557,000</p></td>\n   <td><p>77.8%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ 82,432,000</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Gross Profit (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Gross Profit (Loss)</p></td>\n   <td><p>% Variance vs. Prior</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 73,673,000</p></td>\n   <td><p>61.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 108,964,000</p></td>\n   <td><p>89.2%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ 57,591,000</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Gross Margin</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Gross Margin</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>74.29%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>74.35%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>69.86%</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Operating Profit (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Operating Profit (Loss)</p></td>\n   <td><p>Operating Margin</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 5,001,000</p></td>\n   <td><p>5.0%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 648,000</p></td>\n   <td><p>0.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (50,398,000)</p></td>\n   <td><p>-61.1%</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Net Income (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Net Income (Loss)</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 274,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ (6,678,000)</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (53,598,000)</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Cash Flow From Operations</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Cash Flow From Operations</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 12,044,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 19,645,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (1,427,000)</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p>(Glossary Of Terms)</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>As of June 30, 2021, EngageSmart had $31.8 million in cash and $151.8 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was $25.2 million.</p>\n<p><b>IPO Details</b></p>\n<p>ESMT intends to sell 13 million shares and selling shareholders will offer 1.55 million shares of common stock at a proposed midpoint price of $24.00 per share for gross proceeds of approximately $349 million, not including the sale of customary underwriter options.</p>\n<p>New potential investor Dragoneer Investment Group has indicated an interest to purchase 2.1 million shares of the offering or about $50.4 million at the proposed midpoint price.</p>\n<p>Assuming a successful IPO at the midpoint of the proposed price range, the company's enterprise value at IPO (ex- underwriter options) would approximate $3.7 billion.</p>\n<p>Excluding effects of underwriter options and private placement shares or restricted stock, if any, the float to outstanding shares ratio will be approximately 9.04%. A figure under 10% is generally considered a 'low float' stock which can be subject to significant price volatility.</p>\n<p>Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows:</p>\n<blockquote>\n We expect to use the net proceeds of this offering to repay in full the outstanding borrowings of approximately $114.2 million under our Credit Facilities. We currently intend to use the remaining net proceeds from this offering for general corporate purposes, including to fund our growth, acquire complementary businesses, products, services, or technologies, working capital, operating expenses, and capital expenditures.\n</blockquote>\n<blockquote>\n Source: SEC\n</blockquote>\n<p>Management's presentation of the company roadshow isavailable here.</p>\n<p>Regarding outstanding legal proceedings, management did not disclose any legal claims against the firm as of the regulatory filing date.</p>\n<p>Listed underwriters of the IPO are JPMorgan, Goldman Sachs, BofA Securities, and other investment banks.</p>\n<p><b>Valuation Metrics</b></p>\n<p>Below is a table of the firm's relevant capitalization and valuation metrics at IPO, excluding the effects of underwriter options:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Measure [TTM]</b></p></td>\n   <td><p><b>Amount</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Market Capitalization at IPO</p></td>\n   <td><p>$3,862,956,720</p></td>\n  </tr>\n  <tr>\n   <td><p>Enterprise Value</p></td>\n   <td><p>$3,656,695,720</p></td>\n  </tr>\n  <tr>\n   <td><p>Price / Sales</p></td>\n   <td><p>21.09</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / Revenue</p></td>\n   <td><p>19.96</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / EBITDA</p></td>\n   <td><p>377.37</p></td>\n  </tr>\n  <tr>\n   <td><p>Earnings Per Share</p></td>\n   <td><p>$0.00</p></td>\n  </tr>\n  <tr>\n   <td><p>Float To Outstanding Shares Ratio</p></td>\n   <td><p>9.04%</p></td>\n  </tr>\n  <tr>\n   <td><p>Proposed IPO Midpoint Price per Share</p></td>\n   <td><p>$24.00</p></td>\n  </tr>\n  <tr>\n   <td><p>Net Free Cash Flow</p></td>\n   <td><p>$25,236,000</p></td>\n  </tr>\n  <tr>\n   <td><p>Free Cash Flow Yield Per Share</p></td>\n   <td><p>0.65%</p></td>\n  </tr>\n  <tr>\n   <td><p>Revenue Growth Rate</p></td>\n   <td><p>58.59%</p></td>\n  </tr>\n  <tr></tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>As a reference, a potential public comparable would be NICE Ltd.; shown below is a comparison of their primary valuation metrics:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Metric</b></p></td>\n   <td><p><b>Nice Ltd.</b></p></td>\n   <td><p><b>EngageSmart</b></p></td>\n   <td><p><b>Variance</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Price / Sales</p></td>\n   <td><p>11.01</p></td>\n   <td><p>21.09</p></td>\n   <td><p>91.5%</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / Revenue</p></td>\n   <td><p>10.67</p></td>\n   <td><p>19.96</p></td>\n   <td><p>87.1%</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / EBITDA</p></td>\n   <td><p>41.73</p></td>\n   <td><p>377.37</p></td>\n   <td><p>804.3%</p></td>\n  </tr>\n  <tr>\n   <td><p>Earnings Per Share</p></td>\n   <td><p>$3.05</p></td>\n   <td><p>$0.00</p></td>\n   <td><p>-100.0%</p></td>\n  </tr>\n  <tr>\n   <td><p>Revenue Growth Rate</p></td>\n   <td><p>5.3%</p></td>\n   <td><p>58.59%</p></td>\n   <td><p>1003.34%</p></td>\n  </tr>\n  <tr></tr>\n </tbody>\n</table>\n<p>(S-1/A andSeeking Alpha)</p>\n<p><b>Commentary</b></p>\n<p>ESMT is seeking public investment to pay down debt and for its general unspecified corporate growth plans.</p>\n<p>The firm's financials show strong topline revenue growth and gross profit growth, operating profit and a swing to slight net profit along with growing cash flow from operations.</p>\n<p>Free cash flow for the twelve months ended June 30, 2021, was a solid $25.2 million.</p>\n<p>Selling and Marketing expenses as a percentage of total revenue have dropped as revenue has increased and its Selling and Marketing efficiency rate dropped to 1.1x in the most recent six-month reporting period.</p>\n<p>The company's Rule of 40 performance was excellent and its dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.</p>\n<p>The market opportunity for providing customer engagement software to businesses is large and expected to double in size by the end of 2026, so the company will be helped by strong industry growth dynamics.</p>\n<p>JPMorgan is the lead left underwriter and IPOs led by the firm over the last 12-month period have generated an average return of 20.4% since their IPO. This is a mid-tier performance for all major underwriters during the period.</p>\n<p>The primary risk to the company's outlook is the ability for larger firms to bundle some of their services into their existing offerings, resulting in downward pricing pressure and greater competition.</p>\n<p>As for valuation, compared to partial competitor NICE, ESMT is growing revenue much faster and so its much higher revenue multiples would appear to be justified.</p>\n<p>Also, the company is growing much faster than competitor Pegasystems, so seems to be taking market share from these and other companies in the customer engagement market.</p>\n<p>Given the firm's strong growth and operating metrics versus its competitors, while the IPO isn't cheap, it is worth consideration.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EngageSmart opens for trading at $37, up about 43.6% from IPO price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEngageSmart opens for trading at $37, up about 43.6% from IPO price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-23 23:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 23)&nbsp;<a href=\"https://laohu8.com/S/ESMT\">EngageSmart Inc.</a> opens for trading at $37, up about 43.6% from IPO price.</p>\n<p><img src=\"https://static.tigerbbs.com/835bc9b4ff09e761852f27f75743b887\" tg-width=\"898\" tg-height=\"550\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Company</b></p>\n<p>Braintree, Massachusetts-based EngageSmart was founded to develop a platform that improves customer engagement tailored for certain industry verticals.</p>\n<p>Management is headed by founder and CEO Robert P. Bennett, who has been with the firm since inception and was previously president of Sage Payment Solutions.</p>\n<p>The company's primary offerings include:</p>\n<ul>\n <li>SimplePractice - Wellness</li>\n <li>InvoiceCloud - Government, Utilities and Financial Services</li>\n <li>HealthPay24 - Healthcare</li>\n <li>DonorDrive - Non-profit and Corporate Fundraising</li>\n</ul>\n<p>EngageSmart has received at least $451 million in equity investment from investors including General Atlantic and Summit Partners.</p>\n<p><b>Customer Acquisition</b></p>\n<p>The firm pursues both large enterprise customers and SMB customers via its direct sales force and online service.</p>\n<p>As of June 30, 2021, the firm had served over 68,000 clients in the SMB market and more than 3,000 customers in its Enterprise Solutions segment.</p>\n<p>Selling and Marketing expenses as a percentage of total revenue have dropped as revenues have increased, as the figures below indicate:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling and Marketing</b></p></td>\n   <td><p><b>Expenses vs. Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Percentage</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>32.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>33.1%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>43.1%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The Selling and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling and Marketing spend, dropped slightly to 1.1x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling and Marketing</b></p></td>\n   <td><p><b>Efficiency Rate</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Multiple</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>1.1</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>1.3</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The Rule of 40 is a software industry rule of thumb that says that as long as the combined revenue growth rate and EBITDA percentage rate equal or exceed 40%, the firm is on an acceptable growth/EBITDA trajectory.</p>\n<p>ESMT's most recent calculation was 64% as of June 30, 2021, so the firm is performing well in this regard, per the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Rule of 40</b></p></td>\n   <td><p><b>Calculation</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Recent Rev. Growth %</p></td>\n   <td><p>59%</p></td>\n  </tr>\n  <tr>\n   <td><p>EBITDA %</p></td>\n   <td><p>5%</p></td>\n  </tr>\n  <tr>\n   <td><p>Total</p></td>\n   <td><p>64%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The firm's dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.</p>\n<p>The dollar-based net revenue retention rate metric measures how much additional revenue is generated over time from each cohort of customers, so that a figure over 100% means that the company is generating more revenue from the same customer cohort over time, indicating good product/market fit and efficient sales and marketing efforts.</p>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2021 marketresearch reportby Mordor Intelligence, the global market for customer engagement solutions was an estimated $15.5 billion in 2020 and is forecast to reach $30.9 billion by 2026.</p>\n<p>This represents a forecast CAGR of 12.65% from 2021 to 2026.</p>\n<p>The main drivers for this expected growth are a growth in technology solutions to improve the customer journey via any device they use to connect with businesses.</p>\n<p>Also, a desire to reduce customer churn rate results in improved business financials and growing valuation.</p>\n<p>Below is a chart showing the variation in customer churn rates in different industries in the U.S. in 2018:</p>\n<p><img src=\"https://static.tigerbbs.com/f1066adb602d05e4e99630aacf61e1c5\" tg-width=\"1060\" tg-height=\"922\" referrerpolicy=\"no-referrer\">Major competitive or other industry participants include:</p>\n<ul>\n <li><p>IBM(NYSE:IBM)</p></li>\n <li><p>Microsoft(NASDAQ:MSFT)</p></li>\n <li><p>Nuance(NASDAQ:NUAN)</p></li>\n <li><p>Oracle(NYSE:ORCL)</p></li>\n <li><p>Salesforce(NYSE:CRM)</p></li>\n <li><p>Avaya(NYSE:AVYA)</p></li>\n <li><p>Calabrio</p></li>\n <li><p>Aspect Software</p></li>\n <li><p>Genesys</p></li>\n <li><p>Verint Systems(NASDAQ:VRNT)</p></li>\n <li><p>NICE Ltd.(NASDAQ:NICE)</p></li>\n <li><p>OpenText</p></li>\n <li><p>Pegasystems(NASDAQ:PEGA)</p></li>\n <li><p>Others</p></li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>EngageSmart's recent financial results can be summarized as follows:</p>\n<ul>\n <li><p>Growing topline revenue</p></li>\n <li><p>Increasing gross profit and high gross margin</p></li>\n <li><p>Growing operating profit and net income</p></li>\n <li><p>Increasing cash flow from operations</p></li>\n</ul>\n<p>Below are relevant financial results derived from the firm's registration statement:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Total Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Total Revenue</p></td>\n   <td><p>% Variance vs. Prior</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 99,171,000</p></td>\n   <td><p>58.6%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 146,557,000</p></td>\n   <td><p>77.8%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ 82,432,000</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Gross Profit (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Gross Profit (Loss)</p></td>\n   <td><p>% Variance vs. Prior</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 73,673,000</p></td>\n   <td><p>61.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 108,964,000</p></td>\n   <td><p>89.2%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ 57,591,000</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Gross Margin</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Gross Margin</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>74.29%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>74.35%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>69.86%</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Operating Profit (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Operating Profit (Loss)</p></td>\n   <td><p>Operating Margin</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 5,001,000</p></td>\n   <td><p>5.0%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 648,000</p></td>\n   <td><p>0.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (50,398,000)</p></td>\n   <td><p>-61.1%</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Net Income (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Net Income (Loss)</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 274,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ (6,678,000)</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (53,598,000)</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Cash Flow From Operations</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Cash Flow From Operations</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 12,044,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 19,645,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (1,427,000)</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p>(Glossary Of Terms)</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>As of June 30, 2021, EngageSmart had $31.8 million in cash and $151.8 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was $25.2 million.</p>\n<p><b>IPO Details</b></p>\n<p>ESMT intends to sell 13 million shares and selling shareholders will offer 1.55 million shares of common stock at a proposed midpoint price of $24.00 per share for gross proceeds of approximately $349 million, not including the sale of customary underwriter options.</p>\n<p>New potential investor Dragoneer Investment Group has indicated an interest to purchase 2.1 million shares of the offering or about $50.4 million at the proposed midpoint price.</p>\n<p>Assuming a successful IPO at the midpoint of the proposed price range, the company's enterprise value at IPO (ex- underwriter options) would approximate $3.7 billion.</p>\n<p>Excluding effects of underwriter options and private placement shares or restricted stock, if any, the float to outstanding shares ratio will be approximately 9.04%. A figure under 10% is generally considered a 'low float' stock which can be subject to significant price volatility.</p>\n<p>Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows:</p>\n<blockquote>\n We expect to use the net proceeds of this offering to repay in full the outstanding borrowings of approximately $114.2 million under our Credit Facilities. We currently intend to use the remaining net proceeds from this offering for general corporate purposes, including to fund our growth, acquire complementary businesses, products, services, or technologies, working capital, operating expenses, and capital expenditures.\n</blockquote>\n<blockquote>\n Source: SEC\n</blockquote>\n<p>Management's presentation of the company roadshow isavailable here.</p>\n<p>Regarding outstanding legal proceedings, management did not disclose any legal claims against the firm as of the regulatory filing date.</p>\n<p>Listed underwriters of the IPO are JPMorgan, Goldman Sachs, BofA Securities, and other investment banks.</p>\n<p><b>Valuation Metrics</b></p>\n<p>Below is a table of the firm's relevant capitalization and valuation metrics at IPO, excluding the effects of underwriter options:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Measure [TTM]</b></p></td>\n   <td><p><b>Amount</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Market Capitalization at IPO</p></td>\n   <td><p>$3,862,956,720</p></td>\n  </tr>\n  <tr>\n   <td><p>Enterprise Value</p></td>\n   <td><p>$3,656,695,720</p></td>\n  </tr>\n  <tr>\n   <td><p>Price / Sales</p></td>\n   <td><p>21.09</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / Revenue</p></td>\n   <td><p>19.96</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / EBITDA</p></td>\n   <td><p>377.37</p></td>\n  </tr>\n  <tr>\n   <td><p>Earnings Per Share</p></td>\n   <td><p>$0.00</p></td>\n  </tr>\n  <tr>\n   <td><p>Float To Outstanding Shares Ratio</p></td>\n   <td><p>9.04%</p></td>\n  </tr>\n  <tr>\n   <td><p>Proposed IPO Midpoint Price per Share</p></td>\n   <td><p>$24.00</p></td>\n  </tr>\n  <tr>\n   <td><p>Net Free Cash Flow</p></td>\n   <td><p>$25,236,000</p></td>\n  </tr>\n  <tr>\n   <td><p>Free Cash Flow Yield Per Share</p></td>\n   <td><p>0.65%</p></td>\n  </tr>\n  <tr>\n   <td><p>Revenue Growth Rate</p></td>\n   <td><p>58.59%</p></td>\n  </tr>\n  <tr></tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>As a reference, a potential public comparable would be NICE Ltd.; shown below is a comparison of their primary valuation metrics:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Metric</b></p></td>\n   <td><p><b>Nice Ltd.</b></p></td>\n   <td><p><b>EngageSmart</b></p></td>\n   <td><p><b>Variance</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Price / Sales</p></td>\n   <td><p>11.01</p></td>\n   <td><p>21.09</p></td>\n   <td><p>91.5%</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / Revenue</p></td>\n   <td><p>10.67</p></td>\n   <td><p>19.96</p></td>\n   <td><p>87.1%</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / EBITDA</p></td>\n   <td><p>41.73</p></td>\n   <td><p>377.37</p></td>\n   <td><p>804.3%</p></td>\n  </tr>\n  <tr>\n   <td><p>Earnings Per Share</p></td>\n   <td><p>$3.05</p></td>\n   <td><p>$0.00</p></td>\n   <td><p>-100.0%</p></td>\n  </tr>\n  <tr>\n   <td><p>Revenue Growth Rate</p></td>\n   <td><p>5.3%</p></td>\n   <td><p>58.59%</p></td>\n   <td><p>1003.34%</p></td>\n  </tr>\n  <tr></tr>\n </tbody>\n</table>\n<p>(S-1/A andSeeking Alpha)</p>\n<p><b>Commentary</b></p>\n<p>ESMT is seeking public investment to pay down debt and for its general unspecified corporate growth plans.</p>\n<p>The firm's financials show strong topline revenue growth and gross profit growth, operating profit and a swing to slight net profit along with growing cash flow from operations.</p>\n<p>Free cash flow for the twelve months ended June 30, 2021, was a solid $25.2 million.</p>\n<p>Selling and Marketing expenses as a percentage of total revenue have dropped as revenue has increased and its Selling and Marketing efficiency rate dropped to 1.1x in the most recent six-month reporting period.</p>\n<p>The company's Rule of 40 performance was excellent and its dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.</p>\n<p>The market opportunity for providing customer engagement software to businesses is large and expected to double in size by the end of 2026, so the company will be helped by strong industry growth dynamics.</p>\n<p>JPMorgan is the lead left underwriter and IPOs led by the firm over the last 12-month period have generated an average return of 20.4% since their IPO. This is a mid-tier performance for all major underwriters during the period.</p>\n<p>The primary risk to the company's outlook is the ability for larger firms to bundle some of their services into their existing offerings, resulting in downward pricing pressure and greater competition.</p>\n<p>As for valuation, compared to partial competitor NICE, ESMT is growing revenue much faster and so its much higher revenue multiples would appear to be justified.</p>\n<p>Also, the company is growing much faster than competitor Pegasystems, so seems to be taking market share from these and other companies in the customer engagement market.</p>\n<p>Given the firm's strong growth and operating metrics versus its competitors, while the IPO isn't cheap, it is worth consideration.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ESMT":"EngageSmart Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159478468","content_text":"(Sept 23) EngageSmart Inc. opens for trading at $37, up about 43.6% from IPO price.\n\nCompany\nBraintree, Massachusetts-based EngageSmart was founded to develop a platform that improves customer engagement tailored for certain industry verticals.\nManagement is headed by founder and CEO Robert P. Bennett, who has been with the firm since inception and was previously president of Sage Payment Solutions.\nThe company's primary offerings include:\n\nSimplePractice - Wellness\nInvoiceCloud - Government, Utilities and Financial Services\nHealthPay24 - Healthcare\nDonorDrive - Non-profit and Corporate Fundraising\n\nEngageSmart has received at least $451 million in equity investment from investors including General Atlantic and Summit Partners.\nCustomer Acquisition\nThe firm pursues both large enterprise customers and SMB customers via its direct sales force and online service.\nAs of June 30, 2021, the firm had served over 68,000 clients in the SMB market and more than 3,000 customers in its Enterprise Solutions segment.\nSelling and Marketing expenses as a percentage of total revenue have dropped as revenues have increased, as the figures below indicate:\n\n\n\n\nSelling and Marketing\nExpenses vs. Revenue\n\n\nPeriod\nPercentage\n\n\nSix Mos. Ended June 30, 2021\n32.4%\n\n\n2020\n33.1%\n\n\n2019\n43.1%\n\n\n\nSource: SEC\nThe Selling and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling and Marketing spend, dropped slightly to 1.1x in the most recent reporting period, as shown in the table below:\n\n\n\n\nSelling and Marketing\nEfficiency Rate\n\n\nPeriod\nMultiple\n\n\nSix Mos. Ended June 30, 2021\n1.1\n\n\n2020\n1.3\n\n\n\nSource: SEC\nThe Rule of 40 is a software industry rule of thumb that says that as long as the combined revenue growth rate and EBITDA percentage rate equal or exceed 40%, the firm is on an acceptable growth/EBITDA trajectory.\nESMT's most recent calculation was 64% as of June 30, 2021, so the firm is performing well in this regard, per the table below:\n\n\n\n\nRule of 40\nCalculation\n\n\nRecent Rev. Growth %\n59%\n\n\nEBITDA %\n5%\n\n\nTotal\n64%\n\n\n\nSource: SEC\nThe firm's dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.\nThe dollar-based net revenue retention rate metric measures how much additional revenue is generated over time from each cohort of customers, so that a figure over 100% means that the company is generating more revenue from the same customer cohort over time, indicating good product/market fit and efficient sales and marketing efforts.\nMarket & Competition\nAccording to a 2021 marketresearch reportby Mordor Intelligence, the global market for customer engagement solutions was an estimated $15.5 billion in 2020 and is forecast to reach $30.9 billion by 2026.\nThis represents a forecast CAGR of 12.65% from 2021 to 2026.\nThe main drivers for this expected growth are a growth in technology solutions to improve the customer journey via any device they use to connect with businesses.\nAlso, a desire to reduce customer churn rate results in improved business financials and growing valuation.\nBelow is a chart showing the variation in customer churn rates in different industries in the U.S. in 2018:\nMajor competitive or other industry participants include:\n\nIBM(NYSE:IBM)\nMicrosoft(NASDAQ:MSFT)\nNuance(NASDAQ:NUAN)\nOracle(NYSE:ORCL)\nSalesforce(NYSE:CRM)\nAvaya(NYSE:AVYA)\nCalabrio\nAspect Software\nGenesys\nVerint Systems(NASDAQ:VRNT)\nNICE Ltd.(NASDAQ:NICE)\nOpenText\nPegasystems(NASDAQ:PEGA)\nOthers\n\nFinancial Performance\nEngageSmart's recent financial results can be summarized as follows:\n\nGrowing topline revenue\nIncreasing gross profit and high gross margin\nGrowing operating profit and net income\nIncreasing cash flow from operations\n\nBelow are relevant financial results derived from the firm's registration statement:\n\n\n\n\nTotal Revenue\n\n\nPeriod\nTotal Revenue\n% Variance vs. Prior\n\n\nSix Mos. Ended June 30, 2021\n$ 99,171,000\n58.6%\n\n\n2020\n$ 146,557,000\n77.8%\n\n\n2019\n$ 82,432,000\n\n\n\nGross Profit (Loss)\n\n\nPeriod\nGross Profit (Loss)\n% Variance vs. Prior\n\n\nSix Mos. Ended June 30, 2021\n$ 73,673,000\n61.4%\n\n\n2020\n$ 108,964,000\n89.2%\n\n\n2019\n$ 57,591,000\n\n\n\nGross Margin\n\n\nPeriod\nGross Margin\n\n\nSix Mos. Ended June 30, 2021\n74.29%\n\n\n2020\n74.35%\n\n\n2019\n69.86%\n\n\n\nOperating Profit (Loss)\n\n\nPeriod\nOperating Profit (Loss)\nOperating Margin\n\n\nSix Mos. Ended June 30, 2021\n$ 5,001,000\n5.0%\n\n\n2020\n$ 648,000\n0.4%\n\n\n2019\n$ (50,398,000)\n-61.1%\n\n\n\nNet Income (Loss)\n\n\nPeriod\nNet Income (Loss)\n\n\nSix Mos. Ended June 30, 2021\n$ 274,000\n\n\n2020\n$ (6,678,000)\n\n\n2019\n$ (53,598,000)\n\n\n\nCash Flow From Operations\n\n\nPeriod\nCash Flow From Operations\n\n\nSix Mos. Ended June 30, 2021\n$ 12,044,000\n\n\n2020\n$ 19,645,000\n\n\n2019\n$ (1,427,000)\n\n\n\n(Glossary Of Terms)\n\n\n\nSource: SEC\nAs of June 30, 2021, EngageSmart had $31.8 million in cash and $151.8 million in total liabilities.\nFree cash flow during the twelve months ended June 30, 2021, was $25.2 million.\nIPO Details\nESMT intends to sell 13 million shares and selling shareholders will offer 1.55 million shares of common stock at a proposed midpoint price of $24.00 per share for gross proceeds of approximately $349 million, not including the sale of customary underwriter options.\nNew potential investor Dragoneer Investment Group has indicated an interest to purchase 2.1 million shares of the offering or about $50.4 million at the proposed midpoint price.\nAssuming a successful IPO at the midpoint of the proposed price range, the company's enterprise value at IPO (ex- underwriter options) would approximate $3.7 billion.\nExcluding effects of underwriter options and private placement shares or restricted stock, if any, the float to outstanding shares ratio will be approximately 9.04%. A figure under 10% is generally considered a 'low float' stock which can be subject to significant price volatility.\nPer the firm's most recent regulatory filing, it plans to use the net proceeds as follows:\n\n We expect to use the net proceeds of this offering to repay in full the outstanding borrowings of approximately $114.2 million under our Credit Facilities. We currently intend to use the remaining net proceeds from this offering for general corporate purposes, including to fund our growth, acquire complementary businesses, products, services, or technologies, working capital, operating expenses, and capital expenditures.\n\n\n Source: SEC\n\nManagement's presentation of the company roadshow isavailable here.\nRegarding outstanding legal proceedings, management did not disclose any legal claims against the firm as of the regulatory filing date.\nListed underwriters of the IPO are JPMorgan, Goldman Sachs, BofA Securities, and other investment banks.\nValuation Metrics\nBelow is a table of the firm's relevant capitalization and valuation metrics at IPO, excluding the effects of underwriter options:\n\n\n\n\nMeasure [TTM]\nAmount\n\n\nMarket Capitalization at IPO\n$3,862,956,720\n\n\nEnterprise Value\n$3,656,695,720\n\n\nPrice / Sales\n21.09\n\n\nEV / Revenue\n19.96\n\n\nEV / EBITDA\n377.37\n\n\nEarnings Per Share\n$0.00\n\n\nFloat To Outstanding Shares Ratio\n9.04%\n\n\nProposed IPO Midpoint Price per Share\n$24.00\n\n\nNet Free Cash Flow\n$25,236,000\n\n\nFree Cash Flow Yield Per Share\n0.65%\n\n\nRevenue Growth Rate\n58.59%\n\n\n\n\nSource: SEC\nAs a reference, a potential public comparable would be NICE Ltd.; shown below is a comparison of their primary valuation metrics:\n\n\n\n\nMetric\nNice Ltd.\nEngageSmart\nVariance\n\n\nPrice / Sales\n11.01\n21.09\n91.5%\n\n\nEV / Revenue\n10.67\n19.96\n87.1%\n\n\nEV / EBITDA\n41.73\n377.37\n804.3%\n\n\nEarnings Per Share\n$3.05\n$0.00\n-100.0%\n\n\nRevenue Growth Rate\n5.3%\n58.59%\n1003.34%\n\n\n\n\n(S-1/A andSeeking Alpha)\nCommentary\nESMT is seeking public investment to pay down debt and for its general unspecified corporate growth plans.\nThe firm's financials show strong topline revenue growth and gross profit growth, operating profit and a swing to slight net profit along with growing cash flow from operations.\nFree cash flow for the twelve months ended June 30, 2021, was a solid $25.2 million.\nSelling and Marketing expenses as a percentage of total revenue have dropped as revenue has increased and its Selling and Marketing efficiency rate dropped to 1.1x in the most recent six-month reporting period.\nThe company's Rule of 40 performance was excellent and its dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.\nThe market opportunity for providing customer engagement software to businesses is large and expected to double in size by the end of 2026, so the company will be helped by strong industry growth dynamics.\nJPMorgan is the lead left underwriter and IPOs led by the firm over the last 12-month period have generated an average return of 20.4% since their IPO. This is a mid-tier performance for all major underwriters during the period.\nThe primary risk to the company's outlook is the ability for larger firms to bundle some of their services into their existing offerings, resulting in downward pricing pressure and greater competition.\nAs for valuation, compared to partial competitor NICE, ESMT is growing revenue much faster and so its much higher revenue multiples would appear to be justified.\nAlso, the company is growing much faster than competitor Pegasystems, so seems to be taking market share from these and other companies in the customer engagement market.\nGiven the firm's strong growth and operating metrics versus its competitors, while the IPO isn't cheap, it is worth consideration.","news_type":1,"symbols_score_info":{"ESMT":0.9}},"isVote":1,"tweetType":1,"viewCount":563,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885782549,"gmtCreate":1631834809281,"gmtModify":1676530646232,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Trade safely&nbsp;","listText":"Trade safely&nbsp;","text":"Trade safely","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/885782549","repostId":"1105376345","repostType":4,"repost":{"id":"1105376345","kind":"news","pubTimestamp":1631833833,"share":"https://ttm.financial/m/news/1105376345?lang=&edition=fundamental","pubTime":"2021-09-17 07:10","market":"us","language":"en","title":"S&P ends modestly lower as rising Treasury yields offset robust retail data","url":"https://stock-news.laohu8.com/highlight/detail?id=1105376345","media":"Reuters","summary":"NEW YORK (Reuters) - The S&P 500 ended slightly down on Thursday, paring losses in late trading afte","content":"<p>NEW YORK (Reuters) - The S&amp;P 500 ended slightly down on Thursday, paring losses in late trading after unexpectedly strong retail sales data underscored the strength of the U.S. economic recovery.</p>\n<p>The three major indexes spent much of the day in negative territory as rising U.S. Treasury yields pressured market-leading tech stocks, and the rising dollar weighed on exporters.</p>\n<p>Amazon.com Inc, buoyed by solid online sales in the Commerce Department’s report, helped push the Nasdaq into positive territory.</p>\n<p>“Looking at today, clearly we had positive news from retail sales and it looks as if the massive slowdown in the economy is not materializing as a lot of people expected,” said Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina.</p>\n<p>“It’s a nice reminder that the economy is still taking two steps forward for each step back even amid the COVID concerns,” Detrick added.</p>\n<p>Economically sensitive transports and microchips were among the outperformers.</p>\n<p>Data released before the opening bell showed an unexpected bump in retail sales as shoppers weathered Hurricane Ida and the COVID Delta variant, evidence of resilience in the consumer, who contributes about 70% to U.S. economic growth.</p>\n<p>“Once again, it shows the U.S. consumer continues to spend and continues to help this economy grow,” Detrick said.</p>\n<p>The Dow Jones Industrial Average fell 63.07 points, or 0.18%, to 34,751.32; the S&amp;P 500 lost 6.95 points, or 0.16%, at 4,473.75; and the Nasdaq Composite added 20.40 points, or 0.13%, at 15,181.92.</p>\n<p>Eight of the 11 major sectors in the S&amp;P 500 ended lower, with materials suffering the largest percentage drop.</p>\n<p>The consumer discretionary spending sector posted the biggest gain, with Amazon.com doing the heavy lifting.</p>\n<p>Apparel company Gap Inc gained 1.6%. Online marketplace Etsy Inc and luxury accessory company Tapestry Inc rose 3.1% and 1.9%, respectively.</p>\n<p>Ford Motor Co rose 1.4% after it announced plans to boost production of its F-150 electric pickup model.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.27-to-1 ratio; on Nasdaq, a 1.06-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted nine new 52-week highs and one new low; the Nasdaq Composite recorded 82 new highs and 94 new lows.</p>\n<p>Volume on U.S. exchanges was 9.37 billion shares, compared with the 9.44 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ends modestly lower as rising Treasury yields offset robust retail data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ends modestly lower as rising Treasury yields offset robust retail data\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/usa-stocks/us-stocks-sp-ends-modestly-lower-as-rising-treasury-yields-offset-robust-retail-data-idUSL1N2QI2MB><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (Reuters) - The S&P 500 ended slightly down on Thursday, paring losses in late trading after unexpectedly strong retail sales data underscored the strength of the U.S. economic recovery.\nThe ...</p>\n\n<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-sp-ends-modestly-lower-as-rising-treasury-yields-offset-robust-retail-data-idUSL1N2QI2MB\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-sp-ends-modestly-lower-as-rising-treasury-yields-offset-robust-retail-data-idUSL1N2QI2MB","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105376345","content_text":"NEW YORK (Reuters) - The S&P 500 ended slightly down on Thursday, paring losses in late trading after unexpectedly strong retail sales data underscored the strength of the U.S. economic recovery.\nThe three major indexes spent much of the day in negative territory as rising U.S. Treasury yields pressured market-leading tech stocks, and the rising dollar weighed on exporters.\nAmazon.com Inc, buoyed by solid online sales in the Commerce Department’s report, helped push the Nasdaq into positive territory.\n“Looking at today, clearly we had positive news from retail sales and it looks as if the massive slowdown in the economy is not materializing as a lot of people expected,” said Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina.\n“It’s a nice reminder that the economy is still taking two steps forward for each step back even amid the COVID concerns,” Detrick added.\nEconomically sensitive transports and microchips were among the outperformers.\nData released before the opening bell showed an unexpected bump in retail sales as shoppers weathered Hurricane Ida and the COVID Delta variant, evidence of resilience in the consumer, who contributes about 70% to U.S. economic growth.\n“Once again, it shows the U.S. consumer continues to spend and continues to help this economy grow,” Detrick said.\nThe Dow Jones Industrial Average fell 63.07 points, or 0.18%, to 34,751.32; the S&P 500 lost 6.95 points, or 0.16%, at 4,473.75; and the Nasdaq Composite added 20.40 points, or 0.13%, at 15,181.92.\nEight of the 11 major sectors in the S&P 500 ended lower, with materials suffering the largest percentage drop.\nThe consumer discretionary spending sector posted the biggest gain, with Amazon.com doing the heavy lifting.\nApparel company Gap Inc gained 1.6%. Online marketplace Etsy Inc and luxury accessory company Tapestry Inc rose 3.1% and 1.9%, respectively.\nFord Motor Co rose 1.4% after it announced plans to boost production of its F-150 electric pickup model.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.27-to-1 ratio; on Nasdaq, a 1.06-to-1 ratio favored advancers.\nThe S&P 500 posted nine new 52-week highs and one new low; the Nasdaq Composite recorded 82 new highs and 94 new lows.\nVolume on U.S. exchanges was 9.37 billion shares, compared with the 9.44 billion average over the last 20 trading days.","news_type":1,"symbols_score_info":{".IXIC":0.9,".DJI":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576274545052910","authorId":"3576274545052910","name":"Kevin92","avatar":"https://static.tigerbbs.com/c5ff4addbbdb8d9d15fec29f9709b0c3","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3576274545052910","idStr":"3576274545052910"},"content":"Like and comment","text":"Like and comment","html":"Like and comment"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123053545,"gmtCreate":1624404465287,"gmtModify":1703835476647,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Yes,more positive news that will boost the market&nbsp;","listText":"Yes,more positive news that will boost the market&nbsp;","text":"Yes,more positive news that will boost the market","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":8,"repostSize":0,"link":"https://ttm.financial/post/123053545","repostId":"2145063201","repostType":4,"repost":{"id":"2145063201","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624403890,"share":"https://ttm.financial/m/news/2145063201?lang=&edition=fundamental","pubTime":"2021-06-23 07:18","market":"us","language":"en","title":"U.S. Fed bank stress tests pave way for stock buyback, dividend bonanza","url":"https://stock-news.laohu8.com/highlight/detail?id=2145063201","media":"Reuters","summary":"WASHINGTON, June 22 (Reuters) - The country's largest lenders are poised to start issuing as much as","content":"<p>WASHINGTON, June 22 (Reuters) - The country's largest lenders are poised to start issuing as much as $130 billion in dividends and stock buybacks from next month after the U.S. Federal Reserve gives them what is expected to be a clean bill of health on Thursday, said analysts.</p>\n<p>The Fed on Thursday will release the results of its \"stress tests,\" an annual health check introduced in the wake of the 2009 financial crisis to see how banks would fare in an extreme hypothetical economic downturn.</p>\n<p>Due to pandemic lockdowns, lenders last year weathered a real-life economic crash that was by many measures more extreme than the Fed's imaginary scenario. The downturn prompted the regulator to issue emergency regulatory relief, curb bank capital distributions, and conduct two additional stress tests in 2020.</p>\n<p>Thanks to those measures, plus low interest rates and government stimulus that held off loan losses, analysts expect the country's largest lenders to perform well on Thursday, leading the Fed to lift remaining capital distribution curbs.</p>\n<p>\"The banks entered the crisis well-capitalized, played an important role in the economic response, and now appear set to reward their shareholders with meaningful capital returns,\" said Isaac Boltansky, director of policy research at Compass Point Research &amp; Trading.</p>\n<p>LIFTING CURBS</p>\n<p>The Fed imposed additional limits on bank capital distributions in June 2020 after a COVID-19 \"sensitivity analysis\" showed overall loan losses at 34 large banks could reach $700 billion, with some lenders falling below minimum required capital levels.</p>\n<p>After banks performed well during another stress test in December, the Fed allowed them to resume buying back stock in addition to paying dividends capped at the bank's annual net income.</p>\n<p>In March, the central bank said that it expected to lift those remaining curbs for “most firms” after its stress tests in June provided banks were above regulatory minimum capital levels.</p>\n<p>Broadly speaking, this year's test is more severe than the 2020 scenario the Fed devised prior to the pandemic, which envisioned unemployment peaking at 10%, but is less severe than December's test which put that figure at 12.5%. For 2021, the hypothetical unemployment rate peaks at 10.75%.</p>\n<p>The KBW Bank Index is up about 25% this year compared with a 13% gain in the S&amp;P 500 index, driven in part by expectations banks will pass easily.</p>\n<p>\"This is <a href=\"https://laohu8.com/S/AONE\">one</a> of the positive catalysts that bank investors are looking for this year,\" said David Long, a Raymond James analyst.</p>\n<p>The Fed rules allow lenders to adjust their buybacks and dividends quarterly. Since April, big lenders have issued more than $40 billion in debt to help finance what some analysts expect to be record payouts.</p>\n<p>\"The numbers are big,\" wrote Glenn Schorr, an Evercore ISI analyst. By his estimates the six biggest banks will spend, on average, 122% of earnings on buybacks and dividends in the 12 months beginning July, more than double the ratio of the previous period.</p>\n<p>Those six - $Bank of America Corp(BAC-N)$ , $Citigroup Inc(C-N)$, Goldman Sachs Group Inc , JPMorgan Chase &amp; Co</p>\n<p><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> and Wells Fargo &amp; Co together will increase payouts by $66 billion to $130 billion in the next four quarters, according to Schorr's estimates.</p>\n<p>Goldman Sachs did not respond to a request for comment. The other banks and the Fed declined to comment.</p>\n<p>WELLS WINNER?</p>\n<p>Wells Fargo, which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, is expected to post the biggest jump in payouts - spending an additional $19 billion over the next 12 months by Schorr's estimates.</p>\n<p>All told, the country's fourth-largest lender could pay out 167% of earnings compared with just 28% the previous 12 months, according to Schorr's estimates.</p>\n<p>While the bumper paydays will please shareholders, they are likely to draw ire from Democrats in Washington, who want banks to use their cash to help everyday Americans.</p>\n<p>\"Pressure going forward will be on how to make the...test tougher,” wrote Jaret Seiberg, an analyst at Cowen Washington Research Group.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Fed bank stress tests pave way for stock buyback, dividend bonanza</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Fed bank stress tests pave way for stock buyback, dividend bonanza\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-23 07:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WASHINGTON, June 22 (Reuters) - The country's largest lenders are poised to start issuing as much as $130 billion in dividends and stock buybacks from next month after the U.S. Federal Reserve gives them what is expected to be a clean bill of health on Thursday, said analysts.</p>\n<p>The Fed on Thursday will release the results of its \"stress tests,\" an annual health check introduced in the wake of the 2009 financial crisis to see how banks would fare in an extreme hypothetical economic downturn.</p>\n<p>Due to pandemic lockdowns, lenders last year weathered a real-life economic crash that was by many measures more extreme than the Fed's imaginary scenario. The downturn prompted the regulator to issue emergency regulatory relief, curb bank capital distributions, and conduct two additional stress tests in 2020.</p>\n<p>Thanks to those measures, plus low interest rates and government stimulus that held off loan losses, analysts expect the country's largest lenders to perform well on Thursday, leading the Fed to lift remaining capital distribution curbs.</p>\n<p>\"The banks entered the crisis well-capitalized, played an important role in the economic response, and now appear set to reward their shareholders with meaningful capital returns,\" said Isaac Boltansky, director of policy research at Compass Point Research &amp; Trading.</p>\n<p>LIFTING CURBS</p>\n<p>The Fed imposed additional limits on bank capital distributions in June 2020 after a COVID-19 \"sensitivity analysis\" showed overall loan losses at 34 large banks could reach $700 billion, with some lenders falling below minimum required capital levels.</p>\n<p>After banks performed well during another stress test in December, the Fed allowed them to resume buying back stock in addition to paying dividends capped at the bank's annual net income.</p>\n<p>In March, the central bank said that it expected to lift those remaining curbs for “most firms” after its stress tests in June provided banks were above regulatory minimum capital levels.</p>\n<p>Broadly speaking, this year's test is more severe than the 2020 scenario the Fed devised prior to the pandemic, which envisioned unemployment peaking at 10%, but is less severe than December's test which put that figure at 12.5%. For 2021, the hypothetical unemployment rate peaks at 10.75%.</p>\n<p>The KBW Bank Index is up about 25% this year compared with a 13% gain in the S&amp;P 500 index, driven in part by expectations banks will pass easily.</p>\n<p>\"This is <a href=\"https://laohu8.com/S/AONE\">one</a> of the positive catalysts that bank investors are looking for this year,\" said David Long, a Raymond James analyst.</p>\n<p>The Fed rules allow lenders to adjust their buybacks and dividends quarterly. Since April, big lenders have issued more than $40 billion in debt to help finance what some analysts expect to be record payouts.</p>\n<p>\"The numbers are big,\" wrote Glenn Schorr, an Evercore ISI analyst. By his estimates the six biggest banks will spend, on average, 122% of earnings on buybacks and dividends in the 12 months beginning July, more than double the ratio of the previous period.</p>\n<p>Those six - $Bank of America Corp(BAC-N)$ , $Citigroup Inc(C-N)$, Goldman Sachs Group Inc , JPMorgan Chase &amp; Co</p>\n<p><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> and Wells Fargo &amp; Co together will increase payouts by $66 billion to $130 billion in the next four quarters, according to Schorr's estimates.</p>\n<p>Goldman Sachs did not respond to a request for comment. The other banks and the Fed declined to comment.</p>\n<p>WELLS WINNER?</p>\n<p>Wells Fargo, which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, is expected to post the biggest jump in payouts - spending an additional $19 billion over the next 12 months by Schorr's estimates.</p>\n<p>All told, the country's fourth-largest lender could pay out 167% of earnings compared with just 28% the previous 12 months, according to Schorr's estimates.</p>\n<p>While the bumper paydays will please shareholders, they are likely to draw ire from Democrats in Washington, who want banks to use their cash to help everyday Americans.</p>\n<p>\"Pressure going forward will be on how to make the...test tougher,” wrote Jaret Seiberg, an analyst at Cowen Washington Research Group.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145063201","content_text":"WASHINGTON, June 22 (Reuters) - The country's largest lenders are poised to start issuing as much as $130 billion in dividends and stock buybacks from next month after the U.S. Federal Reserve gives them what is expected to be a clean bill of health on Thursday, said analysts.\nThe Fed on Thursday will release the results of its \"stress tests,\" an annual health check introduced in the wake of the 2009 financial crisis to see how banks would fare in an extreme hypothetical economic downturn.\nDue to pandemic lockdowns, lenders last year weathered a real-life economic crash that was by many measures more extreme than the Fed's imaginary scenario. The downturn prompted the regulator to issue emergency regulatory relief, curb bank capital distributions, and conduct two additional stress tests in 2020.\nThanks to those measures, plus low interest rates and government stimulus that held off loan losses, analysts expect the country's largest lenders to perform well on Thursday, leading the Fed to lift remaining capital distribution curbs.\n\"The banks entered the crisis well-capitalized, played an important role in the economic response, and now appear set to reward their shareholders with meaningful capital returns,\" said Isaac Boltansky, director of policy research at Compass Point Research & Trading.\nLIFTING CURBS\nThe Fed imposed additional limits on bank capital distributions in June 2020 after a COVID-19 \"sensitivity analysis\" showed overall loan losses at 34 large banks could reach $700 billion, with some lenders falling below minimum required capital levels.\nAfter banks performed well during another stress test in December, the Fed allowed them to resume buying back stock in addition to paying dividends capped at the bank's annual net income.\nIn March, the central bank said that it expected to lift those remaining curbs for “most firms” after its stress tests in June provided banks were above regulatory minimum capital levels.\nBroadly speaking, this year's test is more severe than the 2020 scenario the Fed devised prior to the pandemic, which envisioned unemployment peaking at 10%, but is less severe than December's test which put that figure at 12.5%. For 2021, the hypothetical unemployment rate peaks at 10.75%.\nThe KBW Bank Index is up about 25% this year compared with a 13% gain in the S&P 500 index, driven in part by expectations banks will pass easily.\n\"This is one of the positive catalysts that bank investors are looking for this year,\" said David Long, a Raymond James analyst.\nThe Fed rules allow lenders to adjust their buybacks and dividends quarterly. Since April, big lenders have issued more than $40 billion in debt to help finance what some analysts expect to be record payouts.\n\"The numbers are big,\" wrote Glenn Schorr, an Evercore ISI analyst. By his estimates the six biggest banks will spend, on average, 122% of earnings on buybacks and dividends in the 12 months beginning July, more than double the ratio of the previous period.\nThose six - $Bank of America Corp(BAC-N)$ , $Citigroup Inc(C-N)$, Goldman Sachs Group Inc , JPMorgan Chase & Co\nMorgan Stanley and Wells Fargo & Co together will increase payouts by $66 billion to $130 billion in the next four quarters, according to Schorr's estimates.\nGoldman Sachs did not respond to a request for comment. The other banks and the Fed declined to comment.\nWELLS WINNER?\nWells Fargo, which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, is expected to post the biggest jump in payouts - spending an additional $19 billion over the next 12 months by Schorr's estimates.\nAll told, the country's fourth-largest lender could pay out 167% of earnings compared with just 28% the previous 12 months, according to Schorr's estimates.\nWhile the bumper paydays will please shareholders, they are likely to draw ire from Democrats in Washington, who want banks to use their cash to help everyday Americans.\n\"Pressure going forward will be on how to make the...test tougher,” wrote Jaret Seiberg, an analyst at Cowen Washington Research Group.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":360,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3585452666972742","authorId":"3585452666972742","name":"JoelSeah","avatar":"https://static.tigerbbs.com/7209ed7c109a0f0d11e650747fe83336","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3585452666972742","idStr":"3585452666972742"},"content":"good for the market","text":"good for the market","html":"good for the market"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160201016,"gmtCreate":1623798513635,"gmtModify":1703819514875,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Great sharing shall watch the impact&nbsp;","listText":"Great sharing shall watch the impact&nbsp;","text":"Great sharing shall watch the impact","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/160201016","repostId":"1191245053","repostType":4,"repost":{"id":"1191245053","kind":"news","pubTimestamp":1623762167,"share":"https://ttm.financial/m/news/1191245053?lang=&edition=fundamental","pubTime":"2021-06-15 21:02","market":"us","language":"en","title":"Quad-Witch Quandary: How Will Friday's $2 Trillion Gamma Expiration Impact Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1191245053","media":"zerohedge","summary":"Last week, when discussing thebizarre summer doldrumsin the market which pushed the VIX to the lowest level since the onset of the covid pandemic, we said that this period of abnormal market quiet is likely to last until this Friday' quad-witch, when a massive amount of gamma and delta expire and are de-risked, in the process eliminating one of the natural downside stock buffers .So picking up on the topic of Friday' potentially market-moving opex, Goldman' in-house derivatives expert, Rocky Fis","content":"<p>Last week, when discussing thebizarre summer doldrumsin the market which pushed the VIX to the lowest level since the onset of the covid pandemic, we said that this period of abnormal market quiet is likely to last until this Friday' quad-witch, when a massive amount of gamma and delta expire and are de-risked, in the process eliminating one of the natural downside stock buffers (see \"4 Reasons Why The Market Doldrums End With Next Friday's Op-Ex\").</p>\n<p>So picking up on the topic of Friday' potentially market-moving opex, Goldman' in-house derivatives expert, Rocky Fishman, previews June’s upcoming expiration which he dubs as \"large - comparable to a typical quarterly.\" Specifically,<b>there are $1.8 trillion of SPX options expiring on Friday, in addition to $240 billion of SPY options and $200 billion of options on SPX and SPX E-mini futures.</b></p>\n<p><img src=\"https://static.tigerbbs.com/0d1ece116794c7f6523250fd682450e3\" tg-width=\"959\" tg-height=\"765\" referrerpolicy=\"no-referrer\"></p>\n<p>Yet while these totals are massive,<b>when adjusted for the index’s size the amount of expiring options within 10% of current spot is smaller than just about any quarterly over the past decade.</b></p>\n<p><img src=\"https://static.tigerbbs.com/534b677774a92a59d4fe08f09359932b\" tg-width=\"500\" tg-height=\"298\" referrerpolicy=\"no-referrer\"></p>\n<p>It's worth noting that according to Goldman estimates that combos account<b>for 15-20% of SPX options,</b>so an adjusted open interest total would add up to $1.5tln, still much larger than total expiring single stock open interest ($775bln). Furthermore, with stocks at all time highs, it is to be expected that most of the June open interest is below the current SPX spot price. As shown in the chart below, the dual peaks are at 3,900 and 4,150. This means that after Friday, there may be a certain \"anti\"-gravity around those spots until gamma is refilled.</p>\n<p><img src=\"https://static.tigerbbs.com/adfcada2b0ef3f2ebbd684649a613043\" tg-width=\"936\" tg-height=\"541\" referrerpolicy=\"no-referrer\"></p>\n<p>The Goldman strategist then explains what he believes is below the abnormally low level of realized market vol, noting that - as we discussed last week - it is consistent with long gamma positioning. Consider that SPX<b>realized volatility over the past 13 trading days has been just 5.1% - the lowest 13-day realized vol since 2019.</b></p>\n<p><img src=\"https://static.tigerbbs.com/afffda1e07736784ad695d95a9936421\" tg-width=\"952\" tg-height=\"558\" referrerpolicy=\"no-referrer\"></p>\n<p>This contrasts with extreme volatility in pockets of the single stock market; AMC, which had the highest contract volume among single stocks last week (but far less notional volume at$7bln/day than AMZN’s leading $120bln/day), has had close to 400% realized vol over the same period.</p>\n<p><img src=\"https://static.tigerbbs.com/df2b7aeaadb37160a7eaf0ac08ba31de\" tg-width=\"1236\" tg-height=\"561\" referrerpolicy=\"no-referrer\"></p>\n<p>Then, as Nomura's Charlie McElligott first noted last week, Goldman's derivatives team agrees that<b>the extremely low SPX realized volatility is consistent with the possibility that 18-Jun has left “the street” long index gamma, in which case Fishman echoeswhat we said last week, namely that \"realized volatility could pick up once positions are cleaner. \"</b>Meanwhile, the rising beta of VIX futures to the SPX indicates that investors expect short gamma dynamics to pick up should markets sell off. Translation:<u><b>the market will become much more volatile in a selloff.</b></u></p>\n<p><img src=\"https://static.tigerbbs.com/76b01b8a05b70ec4f343626b1fad491b\" tg-width=\"931\" tg-height=\"560\" referrerpolicy=\"no-referrer\"></p>\n<p>Meanwhile, and in keeping with the latest memo stock squeeze, Goldman also notes that while single stock option volumes continue to be high, it is well short of Q1 peaks. The large percentage of all single stock option activity driven by retail, and the predictive value of retail activity, have both heightened the attention on the single stock option market in recent weeks. Recent growth in single stock option activity has been concentrated in low-share-price stocks, leaving a shar prise in contract-volume over the past two weeks that has not been matched by notional volume. When adjusting notional volume for the size of the equity market, Goldman finds that single stock volume has actually been on the low of its 2021 range over the past two weeks which means that the latest ramps had little to no gamma squeeze components to them.</p>\n<p><img src=\"https://static.tigerbbs.com/9c6c3df49e3e5d1e4a7a0d9c24696e6a\" tg-width=\"1212\" tg-height=\"608\" referrerpolicy=\"no-referrer\"></p>\n<p>One final point which we discussed recently and which is in keeping with the growing retail participation in trading, is Goldman's observation that the trend toward shorter-dated SPX options (weeklies) and away from quarterlies, continues. That also is one of the reasons why Friday’s SPX expiration is smaller than many recent quarterlies, and why as it as approached expiration, its trading volume has been falling.</p>\n<p>As Goldman explains, investors have been increasingly adopting the full calendar of SPX expirations, including expirations every Monday and Wednesday, as they tailor their views around events. In fact,<b>the percentage of SPX option volume happening in 3rd Friday expirations is at an all-time low,</b>and is now smaller than the percentage happening in Monday and Wednesday expirations. One explanation for heightened ultra-short-dated volumes is the strong single stock volumes: and here an interest suggesting from Goldman - \"to the extent market makers are unable to cover the short single stock gamma generated by retail investors’ call buying, they may be actively trading long positions in strips of ultra-short-dated SPX index options to offset this gamma.\"</p>\n<p><img src=\"https://static.tigerbbs.com/bd0e886a62a61c70b0f299bd6c032a24\" tg-width=\"954\" tg-height=\"1128\" referrerpolicy=\"no-referrer\"></p>\n<p>Why is this important? because if this trend is large enough, it directly contributes to low implied and realized correlation.<b>Ironically, by ramping single name, \"most-shorted names\", retail investors are ushering a period of unorthodox calm across the rest of the market!</b></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quad-Witch Quandary: How Will Friday's $2 Trillion Gamma Expiration Impact Markets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuad-Witch Quandary: How Will Friday's $2 Trillion Gamma Expiration Impact Markets\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 21:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/quad-witch-quandary-how-will-fridays-2-trillion-gamma-expiration-impact-markets><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Last week, when discussing thebizarre summer doldrumsin the market which pushed the VIX to the lowest level since the onset of the covid pandemic, we said that this period of abnormal market quiet is ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/quad-witch-quandary-how-will-fridays-2-trillion-gamma-expiration-impact-markets\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯","SPY":"标普500ETF",".SPX":"S&P 500 Index"},"source_url":"https://www.zerohedge.com/markets/quad-witch-quandary-how-will-fridays-2-trillion-gamma-expiration-impact-markets","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191245053","content_text":"Last week, when discussing thebizarre summer doldrumsin the market which pushed the VIX to the lowest level since the onset of the covid pandemic, we said that this period of abnormal market quiet is likely to last until this Friday' quad-witch, when a massive amount of gamma and delta expire and are de-risked, in the process eliminating one of the natural downside stock buffers (see \"4 Reasons Why The Market Doldrums End With Next Friday's Op-Ex\").\nSo picking up on the topic of Friday' potentially market-moving opex, Goldman' in-house derivatives expert, Rocky Fishman, previews June’s upcoming expiration which he dubs as \"large - comparable to a typical quarterly.\" Specifically,there are $1.8 trillion of SPX options expiring on Friday, in addition to $240 billion of SPY options and $200 billion of options on SPX and SPX E-mini futures.\n\nYet while these totals are massive,when adjusted for the index’s size the amount of expiring options within 10% of current spot is smaller than just about any quarterly over the past decade.\n\nIt's worth noting that according to Goldman estimates that combos accountfor 15-20% of SPX options,so an adjusted open interest total would add up to $1.5tln, still much larger than total expiring single stock open interest ($775bln). Furthermore, with stocks at all time highs, it is to be expected that most of the June open interest is below the current SPX spot price. As shown in the chart below, the dual peaks are at 3,900 and 4,150. This means that after Friday, there may be a certain \"anti\"-gravity around those spots until gamma is refilled.\n\nThe Goldman strategist then explains what he believes is below the abnormally low level of realized market vol, noting that - as we discussed last week - it is consistent with long gamma positioning. Consider that SPXrealized volatility over the past 13 trading days has been just 5.1% - the lowest 13-day realized vol since 2019.\n\nThis contrasts with extreme volatility in pockets of the single stock market; AMC, which had the highest contract volume among single stocks last week (but far less notional volume at$7bln/day than AMZN’s leading $120bln/day), has had close to 400% realized vol over the same period.\n\nThen, as Nomura's Charlie McElligott first noted last week, Goldman's derivatives team agrees thatthe extremely low SPX realized volatility is consistent with the possibility that 18-Jun has left “the street” long index gamma, in which case Fishman echoeswhat we said last week, namely that \"realized volatility could pick up once positions are cleaner. \"Meanwhile, the rising beta of VIX futures to the SPX indicates that investors expect short gamma dynamics to pick up should markets sell off. Translation:the market will become much more volatile in a selloff.\n\nMeanwhile, and in keeping with the latest memo stock squeeze, Goldman also notes that while single stock option volumes continue to be high, it is well short of Q1 peaks. The large percentage of all single stock option activity driven by retail, and the predictive value of retail activity, have both heightened the attention on the single stock option market in recent weeks. Recent growth in single stock option activity has been concentrated in low-share-price stocks, leaving a shar prise in contract-volume over the past two weeks that has not been matched by notional volume. When adjusting notional volume for the size of the equity market, Goldman finds that single stock volume has actually been on the low of its 2021 range over the past two weeks which means that the latest ramps had little to no gamma squeeze components to them.\n\nOne final point which we discussed recently and which is in keeping with the growing retail participation in trading, is Goldman's observation that the trend toward shorter-dated SPX options (weeklies) and away from quarterlies, continues. That also is one of the reasons why Friday’s SPX expiration is smaller than many recent quarterlies, and why as it as approached expiration, its trading volume has been falling.\nAs Goldman explains, investors have been increasingly adopting the full calendar of SPX expirations, including expirations every Monday and Wednesday, as they tailor their views around events. In fact,the percentage of SPX option volume happening in 3rd Friday expirations is at an all-time low,and is now smaller than the percentage happening in Monday and Wednesday expirations. One explanation for heightened ultra-short-dated volumes is the strong single stock volumes: and here an interest suggesting from Goldman - \"to the extent market makers are unable to cover the short single stock gamma generated by retail investors’ call buying, they may be actively trading long positions in strips of ultra-short-dated SPX index options to offset this gamma.\"\n\nWhy is this important? because if this trend is large enough, it directly contributes to low implied and realized correlation.Ironically, by ramping single name, \"most-shorted names\", retail investors are ushering a period of unorthodox calm across the rest of the market!","news_type":1,"symbols_score_info":{".IXIC":0.9,"SPY":0.9,".DJI":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":462,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3557460658824677","authorId":"3557460658824677","name":"Firework peh","avatar":"https://static.tigerbbs.com/9873e8ddb08004279796752daf19a999","crmLevel":12,"crmLevelSwitch":1,"authorIdStr":"3557460658824677","idStr":"3557460658824677"},"content":"buckle your seat belt","text":"buckle your seat belt","html":"buckle your seat belt"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188245262,"gmtCreate":1623452341656,"gmtModify":1704203889046,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"htmlText":"Good news more vaccines&nbsp;","listText":"Good news more vaccines&nbsp;","text":"Good news more vaccines","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/188245262","repostId":"2142202973","repostType":4,"repost":{"id":"2142202973","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623447457,"share":"https://ttm.financial/m/news/2142202973?lang=&edition=fundamental","pubTime":"2021-06-12 05:37","market":"us","language":"en","title":"Novavax says COVID-19 vaccine shows immune response against Beta virus variant","url":"https://stock-news.laohu8.com/highlight/detail?id=2142202973","media":"Reuters","summary":"June 11 (Reuters) - Novavax Inc said on Friday its experimental COVID-19 vaccine showed immune respo","content":"<p>June 11 (Reuters) - Novavax Inc said on Friday its experimental COVID-19 vaccine showed immune response and protection against the highly contagious coronavirus variant originally identified in South Africa in a clinical trial.</p>\n<p>The vaccine, NVX-CoV2373, is being tested in multiple trials but has yet to be authorized for use in any country.</p>\n<p>Novavax also said studies in mice and baboons found that a different vaccine specifically targeting the South African variant now known as Beta produced immune response and protection, and that it expected to conduct further clinical testing of the Beta-focused vaccine in the fall.</p>\n<p>The company said testing of blood serum of thirty participants of a mid-stage trial who had received both doses of NVX-CoV2373 revealed robust antibody responses to the original version of the coronavirus as well as against the Alpha variant first found in the UK and the Beta variant.</p>\n<p>However, the response against the Beta variant was slightly less, Novavax said.</p>\n<p>The European Medicines Agency started a rolling review of the Novavax shot in February. Data from its pivotal U.S. and Mexico trial is expected to be released in the current quarter.</p>\n<p>The company said the new data is available on the online preprint server bioRxiv and has been submitted for peer review.</p>\n<p>(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli and Bill Berkrot)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax says COVID-19 vaccine shows immune response against Beta virus variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax says COVID-19 vaccine shows immune response against Beta virus variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 05:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 11 (Reuters) - Novavax Inc said on Friday its experimental COVID-19 vaccine showed immune response and protection against the highly contagious coronavirus variant originally identified in South Africa in a clinical trial.</p>\n<p>The vaccine, NVX-CoV2373, is being tested in multiple trials but has yet to be authorized for use in any country.</p>\n<p>Novavax also said studies in mice and baboons found that a different vaccine specifically targeting the South African variant now known as Beta produced immune response and protection, and that it expected to conduct further clinical testing of the Beta-focused vaccine in the fall.</p>\n<p>The company said testing of blood serum of thirty participants of a mid-stage trial who had received both doses of NVX-CoV2373 revealed robust antibody responses to the original version of the coronavirus as well as against the Alpha variant first found in the UK and the Beta variant.</p>\n<p>However, the response against the Beta variant was slightly less, Novavax said.</p>\n<p>The European Medicines Agency started a rolling review of the Novavax shot in February. Data from its pivotal U.S. and Mexico trial is expected to be released in the current quarter.</p>\n<p>The company said the new data is available on the online preprint server bioRxiv and has been submitted for peer review.</p>\n<p>(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli and Bill Berkrot)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142202973","content_text":"June 11 (Reuters) - Novavax Inc said on Friday its experimental COVID-19 vaccine showed immune response and protection against the highly contagious coronavirus variant originally identified in South Africa in a clinical trial.\nThe vaccine, NVX-CoV2373, is being tested in multiple trials but has yet to be authorized for use in any country.\nNovavax also said studies in mice and baboons found that a different vaccine specifically targeting the South African variant now known as Beta produced immune response and protection, and that it expected to conduct further clinical testing of the Beta-focused vaccine in the fall.\nThe company said testing of blood serum of thirty participants of a mid-stage trial who had received both doses of NVX-CoV2373 revealed robust antibody responses to the original version of the coronavirus as well as against the Alpha variant first found in the UK and the Beta variant.\nHowever, the response against the Beta variant was slightly less, Novavax said.\nThe European Medicines Agency started a rolling review of the Novavax shot in February. Data from its pivotal U.S. and Mexico trial is expected to be released in the current quarter.\nThe company said the new data is available on the online preprint server bioRxiv and has been submitted for peer review.\n(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli and Bill Berkrot)","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":871,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":510574240498296,"gmtCreate":1765665613696,"gmtModify":1765665617428,"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3559787818034959","idStr":"3559787818034959"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/QLYS\">$Qualys(QLYS)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/QLYS\">$Qualys(QLYS)$</a>&nbsp;","text":"$Qualys(QLYS)$","images":[{"img":"https://community-static.tradeup.com/news/a05d5ff76d8818f25326c816c20ac48f","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/510574240498296","isVote":1,"tweetType":1,"viewCount":7,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}